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INTRODUCTION: Marine products chemistry 
 
It has long been recognized that natural product structures have 
the characteristics of high chemical diversity, biochemical specificity 
and other molecular properties that make them favourable as lead 
structures for drug discovery. These qualities make them different 
from libraries of synthetic and combinatorial compounds.
1
 
Moreover, the chemical diversity that characterizes the natural 
molecules makes the exploration of their biological properties not 
only a major source of new compounds that could be used for the 
production of drugs, but also a useful tool for the discovery of new 
mechanisms of action. For these reasons, the chemistry of natural 
substances has been making significant progress in recent decades.  
In addition, the growing interest in natural molecules has been 
also favoured by the development of modern biochemical techniques 
and genetics, the advent of new techniques for purification and 
structural determination as well as a series of biological assays 
capable of highlighting the nature and the possible drug activity.  
The ocean, which hosts approximately 87% of the Earth’s life, 
offers huge potential for the discovery of pharmaceutical products. 
The vast ocean, which has an area of about 360 million km
2
, possesses 
incredible resources of novel compounds for investigation by natural 
product chemists, playing a leading role in drug discovery. 
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Unlike terrestrial organisms, marine organisms have to adapt 
to extreme environmental conditions such as high pressure, high salt 
concentration, low nutrient concentration, low but steady temperature 
(except the high temperature near underwater volcanoes and the 
extremely low temperature in polar regions), limited sunlight, and low 
oxygen content. To acclimatize to these conditions, marine organisms 
possess unique characteristics that differentiate them from terrestrial 
organisms in many aspects, such as metabolism, behaviour, 
information transfer, and adaptation strategy. These differences are 




Moreover, the coexistence of an enormous number of species 
that interact each other and with the environment in different ways has 
resulted in organisms which produce chemically diverse compounds 
with a wide variety of possible ecological roles. These include -but are 
not limited to-: a) toxins, which can reduce predation , larval 
settlement and overgrowth by neighbouring organisms; b) compounds 
reducing palatability or nutrient uptake in predators; and c) 
compounds which direct larval settlement and reproduction. Thus, 
among marine organisms, the chance of finding bioactive compounds 
is remarkably higher because many of these compounds are involved 
in their chemical defence, which is essential for the survival of sessile 





The isolation of new substances from marine environment, 
which often exhibit unusual and complex molecular architecture, 
never identified in terrestrial organisms, seems to suggest the 
existence of a separate "Chemistry of the Sea." The diversity of 
organisms in the marine environment has inspired researchers for 
many years to identify novel marine natural products that could 
eventually be developed into therapeutics. By 1974, two marine-
derived natural products (cytarabine, Ara-C and vidarabine, Ara-A) 
were part of the pharmacopeia used to treat human disease.
4
 
From 1984 to 2002, the study of marine natural products and 
the ever-increasing number of new identified metabolites has been 
well documented in the annual reviews by Faulkner,
5,6
 that is 
presently continued by Blunt and co-workers.
7,8
 These reviews 
provide statistics on new compounds of marine origin broadly 
grouped by the organisms from which they are isolated, while giving 
details of reported biological activities. For the year of 2008 alone, 
marine natural product research resulted in the isolation of 1065 new 
compounds whereas in 2009, 13 marine natural products were in 
human clinical trials expecting to be approved as therapeutic agents.
8,9
 
Much of the research into marine natural products is focused on 
finding and assessing compounds with exploitable biological 
activities, for example those with antitumor, antibiotic (as applied to 
many forms of life) and bio-modulating properties. An excellent 
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annual review series on the pharmacology of these compounds has 
been published by Mayer and co-workers for the last 11 years.
10,11
 
There are currently three Food and Drug Administration 







) and ziconotide 
(Prialt
®
). Currently, trabectedin (Yondelis
®
) has been approved by the 
European Agency for the Evaluation of Medicinal Products (EMEA), 
and is completing key Phase III studies in the US for approval (Figure 
1). Concomitantly numerous other marine natural products or 















Figure 1: Marine natural products or derivatives thereof approved for use by the FDA or EMEA, their biological 
source, chemical structures and treatment usage. 
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Table 1: The odyssey of marine pharmaceuticals: a current pipeline perspective (Alejandro M.S. Mayer et al., TRENDS in 
Pharmaceuical Sciences 31, 2010, 255-265). 
Status  Compound name  Trademark  Marine 
organism  
Chemical class  Disease area  
Approved Cytarabine, Ara-C  
Vidarabine, Ara-A  
Ziconotide  
Trabectedin (ET-743)  
(EU Registered only) 
Cytosar-U®  















Phase III Eribulin Mesylate(E7389) 









Phase II DMXBA (GTS-21)  
 






































Phase I Bryostatin 1  


















Aim of the work 
It is increasingly recognized that the oceans preserve a huge 
number of natural products and novel chemical entities, with 
biological activities that may be useful in the quest for finding drugs 




In this light, the aim of my project was to isolate and 
characterize novel molecules from marine organisms with regard to 
the identification of new “lead compounds” for pharmaceutical 
applications. The organisms considered for this study were selected by 
using two different strategies. The first one was based on 
enhancement of the taxonomic diversity. In this process, an emphasis 
was placed on collecting specimens related to - but differing from - 
those known to contain bioactive natural products. The second 
approach was to evaluate ecological factors such as costumer pressure, 
growth form (e.g. thin encrusting), level of resource competition, 
presence or absence of biofouling, etc., and relate this to the 
expression of the secondary metabolism. Some invasive species have 
chemical defences, which may enhance their invasion success, so as 
many marine organisms are soft bodied and have a sedentary life style 
necessitating chemical means of defence. Therefore, they have 
evolved the ability to synthesize or to obtain from marine 
microorganisms bioactive compounds that help them in deterring 
predators, keep competitors at bay or paralyze their prey. 
12 
 
The work presented in this thesis can be divided in two parts. 
The first includes Chapters 1 and 2, dealing with the chemical studies 
of species known to be rich in bioactive natural compounds. The 
second part including Chapter 3 and 4 is based on the chemical 
investigation of organisms selected by ecological observations. 
Each Chapter is dedicated to a different phylum. In particular, 
 Chapter 1 reports the results of the chemical analysis of two 
organisms of the phylum Cnidaria, the Antarctic soft coral 
Alcyonium antarcticum and the Mediterranean sea anemone 
Parazoanthus axinellae; 
 Chapter 2 describes the chemical study of the Mediterranean 
ascidian Pseudodistoma crucigaster, belonging to the phylum 
Chordata; 
 Chapter 3 deals with the chemical investigation of a member of the 
phylum Porifera, the Mediterranean sponge Haliclona fulva; 
 Chapter 4 is dedicated to the phylum Mollusca and includes the 
chemical studies of opisthobranchs Placida dendritica and Aldisa 
andersoni from the Indian Ocean and of the nudibranch Peltodoris 
atromaculata from the Mediterranean Sea.  
The research work has been conducted at the Institute of 
Biomolecular Chemistry (ICB) of CNR, Pozzuoli, Naples, and for a 
limited period of three months at the University of Athens. The 
biological material has been collected by marine biologists of the ICB 
research group in the frame of distinct collection campaigns by scuba 
13 
 
diving. The lipophilic extracts obtained have been fractionated by 
utilizing chromatographic techniques whereas the structure elucidation 
of pure compounds has been carried out by an extensive use of 






CHAPTER 1: Phylum Cnidaria 
 
Cnidaria is a phylum containing over 9,000 species of animals 
found exclusively in aquatic and mostly marine environments.  
The phylum is classified into four main classes: 1) Anthozoa, 
including sea anemones, corals, sea pens; 2) Scyphozoa, containing 
jellyfishes; 3) Cubozoa, that comprises box jellies; 4) and Hydrozoa, a 
diverse group that embraces all the freshwater cnidarians as well as 
many marine forms.  
The class Anthozoa is in turn subdivided into two subclasses 
Octocorallia and Hexacorallia, encompassing corals (e.g. Alcyonium 









1.1.  Alcyonium antarcticum  
 
Alcyonium antarcticum is a 
soft coral belonging to the order 
Alcyonacea reported from Sub Antarctic and Antarctic zones. The 
Antarctic benthic community has been regarded with major interest 
only recently, due to the interest of the scientists. In spite of the low 
temperature, the pronounced seasonality and limitation of food 
reserves, the Antarctic ecosystem appears very rich and stable. To 
date, there are only about 300 natural products (excluding fatty acids 
and sterols) described from Antarctic marine organisms, many of 
which are not found in congeners from temperate and tropical regions. 
Cnidarians represent an ecologically important group in 
Antarctic benthic community and they are recognized to be rich in 
natural products with interesting biological properties.
14
 There are 
about 270 species of Antarctic cnidarians described, but until now 
only eight of them have been studied. The most studied Antarctic 
cnidarians belong to the group of the soft corals (Order Alcyonacea) 
and include Clavularia frankliniana, Alcyonium paessleri and 
Gersemia antarctica.
15 
These three species are chemically defended,
16
 
although they have structural skeletal elements (sclerites). In fact, 
chemo-ecological experiments showed that extracted tissues are not 
ichthyo-deterrent compared to non-extracted tissues, suggesting that 
sclerites have no apparent effect in deterring potential predatory fish. 
16 
 
This indicates that chemical compounds, removed during the organic 
extraction process, are responsible for predator deterrence. Organic 
extracts of Alcyonium paessleri and Gersemia antarctica have also 
been found to possess antifouling and antimicrobial activities. 
Chemical studies on soft corals of the genus Alcyonium 
demonstrated that they are especially rich in terpenes and steroids.
17
 
Recently, the investigation of the lipophilic extract of the soft coral 
Alcyonium grandis led to the isolation of nine new sesquiterpenes 
belonging to the chemical class of illudalanes, which showed strong 







 activities have been reported for alcyopterosins, 
illudalane sesquiterpenes isolated from the sub-Antarctic deep sea soft 
coral Alcyonium paessleri.
18
 Moreover, interesting DNA-binding 




In addition, in 2004, Mellado et al. have found in the Antarctic 
octocoral Anthomastus bathyproctus polyoxygenated steroids 
exhibiting cytotoxic activity against some human tumour cell lines.
23
 
The work here described is the first chemical investigation of 
the soft coral A. antartictum, collected in Terra Nova Bay Antarctica 
and has resulted in the isolation of two new bicyclic sesquiterpenes, 
alcyonicene (1) and deacetoxy-alcyonicene (2),
24
 along with three 














The new compounds 1 and 2 exhibit the rare bulgarane 
skeleton previously described only for metabolites of essential oils 
from Mentha piperita
28
 and Juniperus oxycedrus.
29 
 
1.1.1. Isolation procedure 
The frozen soft coral A. antarcticum (dry weight, 112 g), 
collected in January 2002 during the XVII Italian Campaign in 
Antarctica off Terra Nova Bay (Stazione M. Zucchelli), was chopped 




After removing the organic solvent under reduced pressure, the 
aqueous residue was subsequently extracted with Et2O (200 mL x 4) 
to obtain an oily residue of 3.8 g. The ethereal extract was submitted 
to the first fractionation step, by silica-gel column chromatography, to 
give five fractions: fr. I (550 mg), fr. II (20 mg), fr. III (890 mg), fr. 
IV (810 mg), and fr. V (400 mg). These fractions were subsequently 
purified as described in Table 2 to obtain the pure compounds.  
The known metabolites were identified by comparison of their 
NMR and mass spectral data with those reported in the literature.
25-27 
The structures of compounds 1 and 2, which exhibited a rare 
bulgarane skeleton
30
, never described from the marine environment, 
















Table 2: Purification procedures of the various fractions. 
Fraction Method  Compound 








deacetoxy-alcyonicene (2, 0.5 mg) 
II HPLC n-phase (n-
hexane/EtOAc, 95:5, 
Kromasil analytical 
column, flow rate 1 
mL/min)  
alcyonicene (1, 6 mg) 




pregnenolone-3-acetate (35 mg) 
IV Sephadex LH-20 C/M 1:1 pregnenolone (1.0 mg) 
V Silica-gel column 
chromatography  
(light petroleum/diethyl 
ether gradient, and 
CHCl3/MeOH 8:2) 
pukalide (7.0 mg) 
 
1.1.2. Structure determination 
The molecular formula C17H26O2 of compound 1, named 
alcyonicene, was established by the analysis of the sodiated molecular 
peak at m/z 285.1824 [M+Na]
+
, obtained from the HRESIMS 
spectrum of the sample. This molecular formula indicated five degrees 
of unsaturations. 
Analysis of the 
1
H NMR spectrum of 1 (Figure 2), showed a 
series of methyl signals, at high-field region, that were consistent with 




Figure 2: 1H NMR spectrum of alcyonicene (1) 
 
In particular, two signals at  1.82 (br s, H3-14) and 1.05 (d, J 
= 7.3 Hz, H3-11), each integrating for three protons, were attributed to 
a vinyl methyl and to a secondary sp
3
 methyl, respectively. In 
addition, the low-field region of the 
1
H NMR spectrum showed a 1H 
multiplet at  5.15 (ddd, J = 4.7, 10.8, and 10.8 Hz, H-2) that was 
attributed to a proton linked to an oxygenated carbon, as confirmed by 
its HSQC correlation at C 70.2. Moreover, the spectrum contained 
four 1H broad singlets at  4.91 (H-13a), 4.89 (H-13b), 4.75 (H-15a), 













Figure 3: 13C NMR spectrum of alcyonicene (1) 
 
Four olefinic carbon signals [( 149.5, s, C-10), (147.5, s, C-
12), (112.9, t, C-13), (105.2, t, C-15)] were recognized to belong to 
the two exomethylene groups, whereas one sp
2
 carbon was attributed 
to the carboxyl of the acetyl group, confirmed by an intense IR band at 
1731 cm
-1
. The presence of an acetyl group was also deduced by 
methyl signals  21.5 (COCH3) in the 
13
C NMR spectrum and a 3H 
acetyl singlet at  2.01 (COCH3) in the 
1
H NMR spectrum. The 
remaining two unsaturations required by the molecular formula were 








H COSY experiment showed the presence in the 
molecule of a single spin system, H-1/H2-9 sequence (Table 3), 
22 
 
according to the decaline framework of a cadinene carbon skeleton.
28-
34
 Analysis of the HMBC spectrum of 1 confirmed this hypothesis and 
aided us to assign all the proton and carbon values, as reported in 
Table 3. 
Compound (2), named deacetoxy-alcyonicene, was isolated 
only in trace amount from the extract. The NMR spectra of 2 showed 
proton and carbon resonances very similar to those of 1, indicating the 
presence of the same carbon framework. The only difference was the 
lack of the acetoxy substituent at C-2 in compound 2 with respect to 
compound 1. Accordingly, in deacetoxy-alcyonicene (2), C-2 was a 
methylene rather than an oxygenated methine (in 2: C 23.9, H 
1.65/1.41; in 1: C 70.2, H 5.15). Analysis of  the EIMS spectrum 
showed the molecular peak at m/z 204, confirming the molecular 
formula C15H24.  Careful analysis of 2D NMR experiments as well as 
comparison of the spectroscopic data of the related main metabolite 1  




C NMR values of 2 (Table 3). 
23 
 
Table 3: NMR spectroscopic data for alcyonicene (1) and deacetoxy-alcyonicene (2). 
1 2 
Position 13C,a mb 1H,c m HMBC 13C,a mb 1H,c m 
1 46.9, CH 2.40, m H-2, H-6 42.3, CH 2.08, br t (11.5) 
2 70.2, CH 5.15ax, ddd (4.7,10.8,10.8) H-1, H2-3 23.9, CH2 1.65, m/1.41, m 
3 37.0, CH2 1.92eq, m,  
1.48ax, ddd 
(4.4,10.8,15.8) 
H-2, H3-11, H-4,H2-5 n.d. 1.41, m 
4 27.5, CH 2.13, m, H3-11 27.4, CH 2.04, m 
5                        35.7, CH2 1.66ax, ddd (4.4,13.1,17.5) 
1.25eq, m 
H3-11 n.d. 1.25, m 
6 39.5, CH 1.78, m H-1, H-7 38.6, CH 1.70, m 
7 44.7, CH 2.31eq, br dd (5.3, 5.3) H-6, H2-8, H2-13, H3-14 45.4, CH 2.20, br t (5.18) 
8 32.8, CH2 1.86, m 
1.72, m 
H-7 31.9, CH2 1.83, m 
1.71, m 
9 33.5, CH2 2.38, m 
2.18, ddd (3.9,13.1,13.1) 
H2-8, H2-15 32.6, CH2 2.40, ddd (2.9,13.1,13.1) 
2.17, dt (3.9,13.1) 
10 149.5, C --- H2-15, H-1, H2-9 151.5, C  
11 18.2, CH3 1.05, d (7.3) H-4 17.9, CH3 0.97, s 
12 147.5, C --- H2-13, H3-14 147.7, C  
13 112.9, CH2  4.91, br s 
4.89, br s  
H3-14 112.5, CH2 4.89 br s 
4.85 br s 
14 26.6, CH3 1.82, s H-7, H2-13 26.2, CH3 1.81, s 
15 105.2, CH2 4.75, br s 
4.46, br s 
H2-9, H-1 104.3, CH2 4.69, br s 
4.58, br s 







a Bruker 300 MHz,  values are reported in ppm referred to CDCl3 (c 77.4); 
b Assignments deduced by DEPT sequence; c Bruker 400 MHz, 
values are reported in ppm referred to CHCl3 (H 7.26) 
24 
 
1.1.3.  Stereochemical assignment 
Analysis of the vicinal proton coupling constants (Table 3), 
NOE difference experiments and the 
13
C NMR values allowed the 
establishment of the relative stereochemistry of alcyonicene (1). In 





homodecoupling experiments, simplified the signal at  2.40 (H-1) to 
a large doublet (11.6 Hz) suggesting the presence of a trans-diaxial 
relationship of the two angular protons according to a trans-fused 
ring. 
The relative configuration at C-4 was suggested by the high-
field shifted value of C-11 ( 18.2), consistent with an axial 
orientation of the methyl at C-4. This was in agreement with the 
spectroscopic data reported in the literature for related cadinene 
models exhibiting at C-4 either the equatorial methyl (i.e. cadinane: 
C-11 23.05
31
) or the axial methyl (i.e. xenitorin A: C-11 18.3
32
; 8-epi-
xenitorin A: C-11 18.1
33
). Furthermore, diagnostic NOE effects were 
observed among H3-11, H-6 and H-2 thus inferring the axial 
orientation for all of them (Figure 4). The relative configuration of C-
7 was deduced by the multiplicity of the H-7 signal ( 2.31, br dd, J = 
5.3 and 5.3 Hz), consistent with its equatorial orientation. This 
suggestion was further supported by a series of NOE effects observed 
between H-7 and H-6, H-8ax and H-5eq confirming the proposed 




Figure 4: NOE correlations for alcyonicene (1) 
 
Alcyonicene (1) was thus characterized as possessing a trans-
fused decaline system with the isopropenyl chain at C-7 axially 




Subsequently, with the aim to establish the absolute 
stereochemistry, compound 1 was hydrolyzed in the corresponding 
alcohol derivative to which the modified Mosher’s method could be 
applied. Unfortunately, every attempt was unsuccessful due to the 
rapid degradation of 1 under different hydrolysis conditions. Thus the 
absolute stereochemistry remained undetermined. 
The relative stereochemistry of deacetoxy-alcyonicene 2 was 
suggested to be the same as 1 by both the similarity of the NMR 
values and biogenetic considerations. 
 
1.1.4 . Biological and ecological activities evaluation 
The ecological properties of alcyonicene 1 as well as of known 
compounds 4-methyl-2-[(E)-2-methyl-6-methyleneocta-2,7-dienyl]-
furan, pregnenolone, pregnenolone-3-acetate and pukalide were 
26 
 






The assay against the mosquito fish G. affinis is indicative to 
establish the ichthyotoxic properties of the samples tested. According 
to literature procedures,
36
 all the isolated metabolites were assayed at 
10 ppm, but no significant activity was observed.  
In addition, feeding-deterrence tests against the gold fish C. 
auratus were conducted according to literature procedures.
35
 Among 
the compounds tested, pukalide was feeding-deterrent at a 
concentration of 50 μg/cm
2
. A similar ecological activity has been 
previously reported for a derivative of pukalide, isolated from a soft 
coral and its prey, the aeolid mollusc Phyllodesmium guamensis.
37
 
All compounds were also tested in antimicrobial assays against 
Escherichia coli DH5a and Staphylococcus aureus ATCC6538P.
38
 No 
significant activity was evidenced at 100 µg/mL.  
 
1.2. Parazoanthus axinellae  
 
Parazoanthus axinellae is a sea 
anemone belonging to the order 
Zoanthidea. The chemical investigation 
on this animal started during my stage at the University of Athens.  
Despite evidence of their rich natural product chemistry,
39
 
relatively few chemical studies of zoanthids have been so far reported. 
27 
 
Colonial sea anemones of the genus Parazoanthus have been 
identified in almost all the oceans, and they often have been described 
as epibionts of marine sponges belonging to Agelas or Axinella 
genera. As sponges are known to exude toxic compounds, these 
zoanthids must have developed adaptative tools to minimize effects of 
such toxins. 
P. axinellae has been described to posses three groups of 





 and hydantoins alkaloids.
47
  
The specimens analyzed in this study were collected along the 
Greek coast. The chemical investigation resulted in the isolation of the 
known parazoanthines A-E
 47
 along with two new compounds 3 and 4 




1.2.1. Isolation procedure 
The sea anemone P. axinellae (dry weight 118 g), collected in 
2008, was extracted three times with CH2Cl2/MeOH 1:1. An aliquot of 
the extract (~10 g) was fractionated by VLC, using C18-reverse-phase 
silica gel and a gradient of MeOH/H2O until only MeOH. A 
chromatographic profile (TLC) of the recovered fractions displayed 
the presence of strong UV-visible spots, mainly in the first fraction. 
Due to the complexity of this mixture, the purification of compounds 
was obtained by subsequent chromatographic steps including MPLC 
and then HPLC (RP-amide column, MeOH/H2O gradient). 
parazoanthines –F (3), –A, –B, –G (4), –C, –D and –E were obtained 
in order of decreasing polarity.  
The structures of parazoanthines –F and –G were determined 
by means of spectroscopic methods whereas the known metabolites 
were identified by comparison of their NMR and mass spectral data 
with those reported in the literature.
47  
 
1.2.2. Structure determination 
Analysis of NMR spectra of both compounds 3 and 4 revealed 
a close resemblance with those of co-occurring known parazoanthines 
suggesting the same structural framework.  
The analysis of the ion peak in the HRESIMS spectrum of 
parazoanthine F at m/z 318.1555 [M+H]
+
 led us to deduce the 
29 
 
molecular formula C15H19N5O3. The 
1
H NMR spectrum (Figure 5) of 
parazoanthine F contained a series of proton signals, at low-field 
region, that indicated the presence of an aromatic compound. A para-
substitueted phenolic moiety was easily recognized due to the 
characteristic signals at δH 6.69 (2H, d, J  8.0 Hz, H-16 and H-20) 
and 7.00 (2H, d, J = 8.0 Hz, H-17 and H-19) in the 
1
H NMR spectrum, 
and at δC 126.0 (C, C-15), 132.6 (CH, C-16 and C-20), 116.5 (CH, C-






Figure 5: 1H NMR spectrum of parazoanthine F 
 
An additional unsaturation was evidenced by the presence of 
the 
1
H NMR signals at δH 5.54 (1H, t, J = 7.5 Hz, H-6), and 
13
C 
resonances at δC 129.4 (C, C-5), and 114.3 (CH, C-6). The NMR data 
30 
 
were very similar to those of known parazoanthine B; the difference 
was in the presence of two methylenes [C-13 (δC 58.2; 2H, δH 4.32, t, 
J = 4.5 Hz, H2-13) and C-14 (δC 40.7; 1H, δH 3.10, overlapped; 1H, δH 
2.95, dd, J = 14.4 and 4.5 Hz, H2-14)] in parazoanthine F (3) rather the 
double bond [C-13 (δC 116.5; 1H, δH 6.95, d, J = 15.0 Hz), C-14 (δC 
121.7; 1H, δH 7.42, d, J = 15.0 Hz)]  in parazoanthine B. 
 Table 4: NMR spectroscopic data for parazoanthine F and G (3, 4). 
                             3                                                                  4  
Position 13C,a mb 1H,c m  13C,a mb 1H,c m 
2 168.1, C ---  174.2 --- 
4 161.7, C ---  157.2 --- 
5                        129.4, C ---  55.7, CH 4.20, t (5.0) 
6 114.3, CH 5.54, t (8.0)  29.7, CH2 1.92, m 
1.81, m 
7 27.8, CH2 2.25, m  24.9, CH2 1.75, m 
1.66, m 
8 41.3, CH2 3.15, t (7.5)  41.9, CH2 3.26, t (7.0) 
10 158.2, C ---  162.0 --- 
13 58.2, CH2  4.32, t (4.5)   117.1, CH  7.03, d (15.0)  
14 40.7, CH2 3.10, overlapped 
2.95, dd (14.4, 4.5) 
 121.4, CH 7.48, d (15.0) 
15 126.0, C ---  129.6, C --- 
16-20 132.6, CH 6.69, d (8.0)  128.2, CH  7.37, d (8.0) 
17-19 116.5, CH 7.00, d (8.0)  115.1, CH 6.92, d (8.0) 
18 157.5, C ---  163.1, C --- 
CH3-O    56.9, CH3 3.78, s 
a Bruker 300 MHz,  values are reported in ppm referred to CD3OD (c 49.0); 
b Assignments deduced by DEPT sequence;  
c Bruker 400 MHz, values are reported in ppm referred to CH3OH (H 3.34) 
 
The COSY and HMBC correlations confirmed the sequence of 




Figure 6: Key COSY and HMBC correlations of 3 
 
Compound 4, named parazoanthine G, had the molecular 
formula C16H21N5O3, deduced from HRESIMS spectrum (m/z 
332.2881 [M+H]
+
). This information suggested the addition of a 
methylene unit compared to parazoanthine A, and the close NMR data 
(Table 4) suggested a strong similarity between both compounds. The 
replacement of the hydroxy group in parazoanthine A by a methoxy 
group in parazoanthine G (4) was supported by the 
1
H NMR signal at 
δH 3.78 (3H, s, CH3-O) and the 
13
C NMR resonance at δC 56.9, CH3, 
CH3-O) and was further confirmed by the key CH3-O/C-18 HMBC 
correlation.  
1.2.3. Biological and ecological activities evaluation 
All compounds were tested on different human cancer cell 
lines (Hs683, U373, U251, A549, MCF7, SKMEL28, PC3) to 
evaluate in vitro growth inhibitory concentration, but none of them 
exhibited significant bioactivity.  
32 
 
The main metabolites, the known parazoanthines A and B, 
were tested in vitro Scratch Wound Assay, using different cell lines. 
Mouse B16F10 melanoma, and human A549 non-small-cell lung 
cancer (NSCLC) and Hs683 glioma cells were grown until confluence 
and then a scratch has been performed as detailed in Mathieu V et al. 
2005.
48
 The data indicate that 100 µM of parazoanthine B decreased 
A549 NSCLC migration, while parazoanthine A did not. 
Parazoanthine B also induced weak anti-migratory effects on Hs683 
glioma cells, while parazoanthine A did not. Parazoanthine B did not 
display anti-migratory effects on B16F10 melanoma cells because 
they grew too rapidly in presence of 10% serum. Indeed, the wound 
healing process was already completed in the control condition at 
100% about 12 hrs after having performed the scratch. 
New experiments are ongoing with less proliferating B16F10, 
A549 and Hs683 cancer cells, e.g. in culturing them for 48 hrs in 
presence of 1% serum only. 
Parazoanthines were also analyzed in antimicrobial assays 
against Escherichia coli DH5a and Staphylococcus aureus 
ATCC6538P. The experiments were performed in triplicate at 




CHAPTER 2: Phylum Chordata 
 
Chordates are animals which are either vertebrates or one of 
several closely related invertebrates. This phylum consists of three 
subphyla: Urochordata, represented by tunicates, Cephalochordata, 
represented by lancelets, and Craniata, including vertebrata.  
Tunicates, also known as ascidians, are a group of underwater 
saclike marine invertebrate filter feeders, characterized by a tough 
"tunic" outer made of polysaccharides. 
Ascidians are found all over the world and, usually, are sessile 
animals. They remain firmly attached to substrata such as rocks and 
shells. There are 2,300 species of ascidians and three main types: 
solitary ascidians, social ascidians, that form communities through the 
aggregation of each other at their bases, and colonial ascidians that 
consist of several small individuals (called zooids) forming colonies 
up to several meters in diameter. 
Tunicates are the natural prey of many animals, including 
molluscs, flatworms, rock crabs, sea stars, fish and sea otters. They are 
able to chemical defend themselves by maintaining an extremely high 
concentration of vanadium in the blood, having a very low pH of the 
tunic (due to an acid in easily-ruptured bladder cells), and /or 
producing secondary metabolites harmful to predators and invaders. 




Ascidians are renowned for their great chemical diversity and, 
during the last 25 years, they have been shown to produce an array of 
cytotoxic molecules. The high potential of these organisms as a new 
source of antitumor compounds is demonstrated by the fact that 
among the first six marine derived compounds that have reached 
clinical trials as antitumor agents, three are derived from ascidians.
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Ecteinascidin-743 (ET-743/trabectedin), isolated from the Caribbean 
tunicate Ecteinascidia turbinata, represents a significant milestone in 
the development of marine derived drugs. Almost 40 years after its 
discovery and 17 years after the publication of its structure, it became 
the first marine-derived anticancer drug to reach the market. However, 
ET-743 was not the unique lead anticancer agent found from marine 
ascidians.
50 
Two closely related compounds - didemnin B and aplidine 
(Figure 7) isolated from the tropical Trididemnum solidum and the 
Mediterranean Aplidium albicans, respectively - have been 
extensively investigated for more than 20 years; although clinical 
trials for didemnin B were stopped in the mid-1990s. Differently, 
phase II clinical trials with aplidine are ongoing in indications that 
include metastatic melanoma, multiple myeloma, non-Hodgkin’s 





Figure 7: Didemnin B from Trididemnum solidum and aplidine (also known as 
dehydrodidemnin B) from Aplidium albicans 
 
2.1. Pseudodistoma crucigaster  
 
Among tunicates, the genus 

















The Mediterranean Pseudodistoma crucigaster
52 
has been 
reported to contain linear erythro 2-amino-alken-3-ols, crucigasterins 
(i.e., crucigasterin 277). These molecules are closely related to the 
sphingosines,
66
 basic building blocks of sphingolipids and 
glycosphingolipids, that are constituents of cell walls and membranes 
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and play diverse roles in biological processes such as cell growth, cell 
differentiation, and the immune response.
67 
In this study, we have analyzed specimens of Mediterranean P. 
crucigaster, collected off the coasts of Sardinia. The chemical 
investigation has led to the structural elucidation of five novel 
unsaturated amino alcohols, crucigasterins A-E (5-9),
68
 isolated along 






These molecules, which exhibit different carbon chain length 
and oxidation degree, are all characterised by the threo-configuration 
of the amino alcohol moiety, in contrast with the erythro-
stereochemistry of previously reported crucigasterins.
52
 
All compounds have been characterised as diacetyl derivatives 
5a-10a. In addition, a complete NMR assignment of the diacetyl 
37 
 
derivative of known compound 10a,
53
 which previously was not fully 
characterized, has been also made.  
 
2.1.1. Isolation procedure 
The colonial ascidian P. crucigaster (dry weight, 5.2 g), 
collected along the Sardinia coast, was extracted exhaustively with 
Me2CO using ultrasound. After filtration and evaporation in vacuum 
of the organic solvent, the residue was subsequently extracted with 
Et2O and BuOH to obtain two gummy residues (0.783 g and 0.976 g, 
respectively). The ethereal extract was fractionated by a silica gel 
column chromatography using a gradient eluent system with 
increasing polarity. A preliminary NMR analysis of the recovered 
fractions revealed that the most polar fraction was constituted by a 
complex mixture of unsaturated amino alcohols. Any effort to separate 
this mixture was unsuccessful, also due to the degradation of the 
compounds observed during the purification steps.  
Thus, the fraction was acetylated with acetic anhydride and 
pyridine (2 h, room temperature). The acetylated mixture was easily 
fractionated by reverse-phase HPLC (MeOH/H2O 8:2) to give six pure 
metabolites, the diacetyl derivatives 5a-10a of five novel molecules, 
named crucigasterins A-E (5-9), and the diacetyl derivative 10a of 
known related compound 10. Compound 10a was identified by 
comparison of spectroscopic data with the literature
53
 even though 
only a partial NMR assignment had been reported. However, the 
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proton and carbon resonances of 10a were fully assigned, by 
interpretation of 2D-NMR spectra, in Tables 5 and 6. 
 
2.1.2. Structure determination 
Analysis of the NMR spectra of compounds 5a-9a revealed a 
close structural relationship with compound 10a indicating the 
presence in all the molecules of the same 2-amino-3-hydroxy-alkyl 
residue. The structural differences among them were in either the alkyl 
chain length or in the number and/or geometry of the double bonds.  
Diacetyl crucigasterin A (5a) was considered first. The 2-
amino-3-hydroxy moiety was  easily recognized by sequentially 
correlated proton signals at  1.10 (3H, d, J = 6.7 Hz, H3-1), due to the 
terminal methyl, and at  4.25 (1H, dq, J = 3.8 and 6.7 Hz, H-2) and 
4.85 (1H, dt, J = 3.8 and 6.7 Hz, H-3), that were attributed to two 
methines linked to the amino and the hydroxyl group, respectively 
(Figure 8). Moreover, the 
13
C NMR spectrum displayed carbon signals 





Figure 8: 1H NMR spectrum of diacetyl crucigasterin A (5a) 
In addition, the carbon resonances indicated the presence of 
three double bonds (Table 6), one of which had to be in the terminal 
position. Accordingly, the 
1
H NMR spectrum displayed in the low-
field region seven olefinic signals (Table 5), which were assigned to a 










double bonds were suggested to be E,E by the coupling constants 
(J5,6=J7,8=14.6 Hz) and further supported by the 
13
C chemical shift 
values of the allylic methylene carbons C-4 ( 35.0) and C-9 (32.3) 






Diacetyl crucigasterin B (6a) had the same molecular formula 





NMR spectra (Tables 5 and 6) indicated the presence of an identical 
structural sequence: they differed only in the geometry of 
5
 double 
bond. In particular, the proton coupling constant J5,6=10.0 Hz and the 
carbon values of C-4 (d 29.5) and C-7(d 27.3) clearly indicated that 6a 
was the 5Z-isomer of 10a.  
Diacetyl crucigasterin C (7a), with the molecular formula 
C22H33NO3, contained a highly unsaturated C18 alkyl chain. The 
1
H 
NMR spectrum showed signals accounting for 11 olefinic protons 
(Table 5) according to the presence of five vinyl unsaturations (four 
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disubstituted and one terminal double bond). The terminal vinyl 
moiety was conjugated with one of the disubstituted double bonds, 





COSY spectrum revealed that the 6H signal at  5.42-5.33 was 
coupled with three bis-allylic methylene groups at  2.97 (2H, app. t, J 
= 5.6 Hz, H2-14), 2.84 (2H, app. t, J = 5.6 Hz, H2-8 or H2-11) and 2.79 
(2H, app. t, J = 5.6 Hz, H2-11 or H2-8), and to an allylic methylene at 
 2.02 (2H, m, H2-5). This latter signal was additionally correlated 
with the methylene multiplet at  1.61 (2H, m, H2-4), which in turn 
showed cross-peaks with the carbinol proton of 2-amino-3-hydroxy 
moiety. The 
13
C NMR values of bis-allylic and allylic methylenes 
(Table 6) suggested the Z geometry of all the disubstituted double 
bonds.  
Diacetyl crucigasterin D (8a) was characterized by two 




C NMR spectra exhibited signals attributable to two 
disubstituted double bonds [C 134.1(C-6),130.5 (C-9), 128.2 (C-10), 
124.4 (C-5); H 5.51 (H-6), 5.41-5.28 (H-5, H-9 and H-10)], in 
addition to the signals due to the 2-amino-3-hydroxy moiety (Tables 5 




H COSY correlations was diagnostic to 
establish the position of the two double bonds at C-5 and at C-9. The 
geometry of 
5,6
 double bond was assigned as E by the proton 
coupling constant J5,6=14.0 Hz and the 
13
C NMR chemical shift values 





 double bond was suggested to be Z by the chemical 
shift values of the remaining allylic methylenes [ 27.1 (C-8) and 27.3 
(C-11)].  
Diacetyl crucigasterin E (9a) had the molecular formula 
C22H37NO3, consistent with a C18 alkyl chain with three double bonds. 
In fact, the 
1
H NMR spectrum of 9a showed three olefinic signals 
(Table 5), a signal at  2.76 (2H, app. t, 5.8 Hz), which was due to a 
bis-allylic methylene group, and multiplets centred at  2.24 (2H, m, 
H2-4), 2.10 (2H, m, H2-8), 2.06 (2H, m, H2-7) and 2.02 (2H, m, H2-




H COSY experiment helped to locate the three double bonds. The 
geometry of the three double bonds was suggested by the 
13
C NMR 
values (Table 6) of bis-allylic and allylic methylenes resonating at  
25.7 (C-11), 27.0 (C-8), 27.2 (C-14), 32.6 (C-7), and 35.0 (C-4) 




 double bonds and 
the E stereochemistry for 
5
 double bond.  
 
2.1.3. Stereochemistry assignment 
With the aim to establish the relative configuration of the 
chiral centers C-2 and C-3 in the novel crucigasterins, a series of NOE 
difference experiments were recorded on the oxazolidinone derivative 
(11)  of crucigasterin A (5), according to the procedure applied for 
related molecules.
53,54
 In order to prepare the oxazolidinone, the 
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diacetyl derivative 5a (1 mg) was treated with NaOH (4 M) at 70 °C 
for 20 h, to obtain the free aminoalcohol (0.8 mg, 5), that was then 
reacted with 1,10-carbonyldiimidazole (3 mg) in 1 mL of CH2Cl2 and 
100 mL of DMF at 0 °C for 19 h under argon atmosphere. The 
solution was extracted with water and the organic layer was dried 




The NOE effects observed between H-3 and H3-1 and between 
H-2 and H2-4 suggested that the substituents at both C-2 and C-3 were 
on the opposite face of oxazolidinone ring. Consequently, H-2 and H-
3 were suggested to be in a threo relationship in the acyclic starting 
compound 5. This suggestion was definitively confirmed by a 
comparative analysis of NMR data of diacetyl crucigasterin A (5a) 
with those reported in the literature for synthetic threo and erythro 2-
acetamido-3-acetoxy-5E,7E-tetradecadiene models.
69
 A good 
agreement of carbon NMR resonances was observed between 5a and 
the threo-isomer, in particular with regards to diagnostic 
13
C chemical 
shift value of C-1 (threo 18.49; erythro 14.93; 5a 18.5). On this basis, 
the relative configuration of 5a, and consequently of 5, was assigned 
to be threo (2R*,3R* or 2S*,3S*). Consequently, the threo 
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stereochemistry of the 2-amino-3-hydroxy moiety of all the other 
crucigasterins was assigned by the indicative 
13
C NMR value of the 
terminal methyl C-1. 
The next step was to assign the absolute stereochemistry of 
crucigasterins by applying the Mosher method to suitable derivatives. 
Unfortunately, during the methanolysis to obtain the hydroxyl 
substrates, a significant degradation was observed to occur under the 
reaction conditions for most compounds preventing the formation of 
the desired hydroxyl derivates. However, the reaction was 
successfully applied on the known co-occurring compound 10a, the 




The O-deacetyl derivative 10b, obtained by treatment with 
Na2CO3 in anhydrous MeOH of 10a, was treated with (R)- and (S)-
MTPA chlorides to get the (S)- and (R)-MTPA esters 10c and 10d, 
respectively. The (Sester-Rester) values observed (Figure 9) for the 
signals of protons close to the hydroxyl group at C-3 indicated the S 
configuration as depicted in formula 10b. Consequently, the absolute 







Figure 9: Chemical shifts differences (Sester-Rester) between (S)- and (R)-MTPA 
derivatives of compound 10a 
 
The same configuration was suggested for the other 
crucigasterins based on biogenetic considerations. This suggestion 
was supported by the optical rotation values of diacetyl derivatives of 
crucigasterins (5a-10a), which were all laevorotatory according to the 
2S absolute configuration.
69
 Particularly diagnostic was the 
comparison of the []D value of diacetyl derivative of crucigasterin A 
(5a) {[]D -20.3 (c 0.03, CH3OH)} with those reported for synthetic 
(2R,3R)-{[]D +20.7 (c 1.66, CH3OH)} and (2S,3S)-{[]D -20.6 (c 
0.32, CH3OH)} 2-acetamido-3-acetoxy-5E,7E-tetradecadiene 
enantiomers
69,70
 further confirming the 2S,3S absolute configuration 
for 5a and for all co-occurring metabolites. 
 
2.1.4. Biological and ecological activities evaluation 
Selected diacetyl-crucigasterins have been tested for 
antibacterial and antifungal activities, exhibiting moderate activity 
against E. coli and C. albicans, respectively. 
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Antifungal assay was performed by the broth macrodilution 
method following the guidelines of the National Committee for 
Clinical Laboratory Standards (NCCLS) document M27-P.
71, 72
 MIC 
was defined as the lowest concentration of the compound that 
completely inhibited the growth of the test organism.  
The antibacterial assay was performed by using the same 
method as the antifungal test, only differing in the assay medium and 
in the incubation temperature.  
In particular, the diacetyl-crucigasterins B (6a) and E (9a) 
were found to be active at 50 g/mL against both E. coli and Candida 
albicans, and at 100 g/mL against E. coli, respectively. 
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CHAPTER 3: Phylum Porifera 
 
Among the organisms that inhabit the seas, Porifera, 
commonly known as sponges, comprising the most primitive 
multicellular animals. These sessile organisms have world-wide 
distribution and live anchored to substrates, such as rocks, seaweed, 
shells and crabs. Sponges could have solitary life or make dense 
colonies that become important habitats for animals and plants: their 
cavities can host several symbionts as small crustaceans, insect larvae, 
algae, cyanobacteria, etc. 
Porifera are filter-feeders that use flagellated cells to pump 
water into their canal systems. They can be encrusting or erect, 
assuming different morphologies according to the environmental 
characteristics (substrate, currents, waves). Schematically, the body of 
a sponge may be considered a sort of bag, all perforated (hence the 
name Porifera) from inhalants thin pores (orifices), with a large 
opening said exhaling pore or osculum and an inner chamber called 
gastral cavity or spongocele.  
Depending on the different endoskeleton, phylum Porifera is 
divided into four classes: 1) Calcispongiae, that are characterized by 
calcareous skeletons, generally small or tabular; 2) Hexactinellida 
(Hyalospongiae), also known as vitreous sponges due to their siliceous 
skeleton, with a funnel or cylindrical shape; 3) Demospongiae (mostly 
sponges species, 90%), including animals whose skeleton is composed 
of siliceous spicules, which in some forms are partially or fully 
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replaced by skeletal elements consisting of a special protein called 
spongin; 4) Sclerospongiae, a small group of sponges, mostly tropical, 
whose skeleton consists of calcium carbonate crystals on a network of 
organic fibbers. 
Even sponges are primitive organisms, they have proved to be 
a rich source of secondary metabolites. It has been repeatedly 
suggested
73-75
 that they are protected by toxic or noxious chemicals, 
i.e. allomones. Many of these molecules, often characterized by 





3.1. Haliclona fulva 
 
Haliclona fulva is an encrusting and 
orange desmosponge with a globular shape. 
A previous chemical study on this sponge 
has reported the isolation of a series of 
bioactive polyacetylenes,
78-80
 closely related to petroformines, a 
family of long chain polyacetylenes isolated from another 
Mediterranean sponge, Petrosia ficiformis.
81
 All these compounds 
display linear alkin chain of 46 carbons with a characteristic 1-yn-3-
ol-4-ene moiety at each terminus. In closely related haplosclerid 
sponges,
82
 similar polyacetylenes usually only have a mono-terminal 






The biological interest of polyacetilene molecules prompted us 
to chemically reinvestigate H. fulva. The work here described reports 
the isolation and spectroscopic elucidation of nine high molecular 
weight polyoxygenated acetylenes, fulvynes A-I (12-20),
88
 from the 
butanolic extract of a specimen of the sponge collected in the Gulf of 
Naples.  
 
The new compounds are characterized by a long linear alkyl 
chain bearing a residue of propargylic acid, a terminal acetylenic 
moiety, a diacetylenic carbinol and several hydroxyl and keto groups. 
Previous isolated metabolites – fulvinol and renierines - have been 
detected in the ether extract of the sponge under investigation along 
with a mixture of additional non-polar polyacetylenes. These latter 
metabolites have been also found in the lipophilic extract of the 
nudibranch Peltodoris atromaculata, which was observed grazing on 
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H. fulva. The structure elucidation of these compounds will be 
describe in the next Chapter, dedicated to the phylum Mollusca. 
 
3.1.1. Isolation procedure 
The sponge H. fulva (dry weight, 42 g), collected along the 
coast of Procida Island (Gulf of Naples) at a depth of ~ 40 m, was 
chopped and then extracted with Me2CO using ultrasound. After 
filtration and evaporation of the organic solvent in vacuo, the residue 
was subsequently extracted with Et2O and BuOH. Both organic phases 
were dried to give two gummy residues (1.46 g and 2.48 g, 
respectively) which were tested in preliminary antimicrobial and 
antifungal assays at a fixed concentration (50 µg/mL). The butanol 
extract showed a good activity against the gram positive B. subtilis 
whereas it showed weak against E. coli and C. albicans , with respect 
to the ethereal extract. Therefore, part of the bioactive butanol extract 
(1.2 g) was thus subjected to Sephadex LH-20 chromatography in 
MeOH to give eight fractions (I-VIII). Preliminary 
1
H NMR analysis 
of these fractions showed that fraction III (0.228 g) contained a 
mixture of polyacetylenic compounds. An aliquot of this fraction 
(0.120 g) was further purified on RP-amide semipreparative HPLC 
column with a gradient of H2O/MeOH/TFA (from 29:70:0.1 to 100% 
MeOH, flow 2.0 mL min
-1
) to afford, in order of retention time, pure 
fulvynes A-I (12-20). Preliminary 
1
H NMR analysis revealed that all 
isolated molecules were polyhydroxylated acetylenes. In particular, 
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comparison of the spectra with literature data showed strong 





polyacetylene compounds isolated 
from other Haliclona species.  
The structures of compounds 12-20 were determined by an 
extensive use of spectroscopic techniques. 
3.1.2. Structure determination 
Among the fulvynes, compound 14, named fulvyne C, was the 
most abundant metabolite. As deduced from the sodiated molecular 
ion peak at m/z 851.4879 [M+Na]
+
 in the HRESIMS, fulvyne C (14) 




H NMR spectrum of 14 (Figure 10) displayed signals due 
to four olefinic protons [H 5.44, dd (15.2, 7.0); 5.64, dt (15.2, 6.7); 
5.79, dd (15.5, 5.4); 5.92, dd (15.5, 6.0)], an acetylenic proton at (H 
2.93), nine oxygenated methines in the range H 5.14-347 and a series 





Figure 10: 1H NMR spectrum of fulvyne C (14) 
 
The IR spectrum showed bands at 2237, 1696, and 1679 cm
-1
 
suggesting the presence of triple bonds and carbonylic functions. The 
13
C NMR spectrum (Figure 11) showed eight sp carbon resonances in 
the range at C 85.3-74.8, due to four triple bonds, and C=O signals at 
C 157.2 and 213.6. Moreover, carbon resonances due to sp
2
 carbons 
of two double bonds in the range C 136.3-130.5, nine oxygen-bearing 
methines in the region of the field between C 78.4 and 52.5, and 







Figure 11: 13C NMR spectrum of fulvyne C (14) 
 
All proton-bearing carbons were assigned by the HSQC 




H COSY spectrum aided us to 
recognize the partial structures a-e in the long alkyl chain of 14 
(Figure 12).  
 
 
Figure 12. Partial structures of fulvyne C (14) as deduced 












H TOCSY experiment was essential to assemble 
fragments a-e. In particular, the oxymethine H-42 in partial structure a 
was correlated to the oxymethine H-38 in moiety b through an 
additional methylene H2-40 (H 1.55-1.51, C 22.6). The -carbonyl 
methylene H2-28 in fragment c showed correlations with methylene 
H2-31 in fragment b through methylene H2-30 (H 1.56-1.50, C 29.0), 
whereas the other -carbonyl methylene H2-26 had cross-peaks with 
the allylic methylene H2-22 in partial structure d through an additional 
methylene H2-24 (H 1.38-1.30, C 30.4). The observed correlations 
allowed to connect fragments a-d accounting for a C30 segment of the 
alkyl chain of 14. This implied that fragment e had to be linked to the 
remaining part of the molecule through nine additional methylenes 
thus satisfying the molecular formula. Analysis of the HMBC 
spectrum of 14 confirmed the proposed structure and enabled us to 
assign properly the acetylenic quaternary carbon resonances (Table 8).  
The geometries of the two double bonds were easily assigned as 20E, 
43E by the coupling constant analysis of the olefinic protons (J = 15.2 
and 15.5 Hz, respectively).  
Fulvyne A (12) had the same molecular formula C47H72O12 as 
fulvyne C (14). Comparison of 1D and 2D proton NMR spectra of 12 
with those of 14 disclosed a substantial structural analogy between the 
two compounds suggesting the presence of the same functional 
groups. In particular, the differences were limited to the partial 
structure b' where one of the two hydroxyl groups of the vicinal diol 
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(37-OH) in fulvyne C was shifted on the other side of the di-yne 
moiety at C-31 in 12 (Figure 13).  
The remaining signals appeared to be the same as compound 
14 thus confirming that the two polyacetylenes were positional 
isomers.  
Fulvyne B (13) was also an isomer of fulvyne A (12) and 
fulvyne C (14). The proton and carbon spectra of 13 displayed signals 
that were strongly reminiscent with those of 14 being consistent with 
the same partial structures a-e. Analysis of 2D NMR spectra, 
especially TOCSY experiment, clearly demonstrated that the sequence 
of fragments b, c, and d in fulvyne B (13) was different from that set 
in fulvyne C (14). In particular, the keto group was positioned far 
from the inner triple bonds. In fact, the methylene protons at H 2.26 
(H2-31) were long-range correlated with the allylic oxymethine at H 
4.00 (H-28), rather than one of the -carbonyl methylene as in 
compound 14. In addition, the -carbonyl methylene at H 2.47 (H2-
21) had a clear correlation with the allylic methylene at H 2.07 (H2-
25), consistent with the sequential connection in the chain of 










Figure 13. Additional partial structures of fulvynes 
 
 
The molecular formula C47H72O11 of fulvyne D (15), as 
deduced from the sodiated peak at m/z 835.4865 in the HRESIMS, 
indicated that 15 was lacking in an oxygen atom with respect to co-
occurring 12-14. In addition, the 
13
C NMR spectrum evidenced the 
presence of eight oxygen-bearing carbons (Table 8) rather than nine 
oxymethines, such as in 12-14. Analysis of 2D NMR experiments of 
fulvyne D indicated that the partial structure b'' lacked the hydroxyl 
group in -position of di-yne moiety present in fulvyne C. In fact, the 
COSY spectrum showed that the bis propargyl alcohol proton at H 
5.07 (H-34) was coupled with two methylene groups at H 2.25 (H2-
31) and H 2.40 (H2-37), that had to be both linked to internal triple 
bonds. By TOCSY experiments, the fragments were assembled as in 
fulvyne B (13). Thus fulvyne D (15) was the 37-dehydroxy derivative 
of 13.  
Fulvyne E (16) with the molecular formula C47H72O11 was 
isomeric with compound 15, from which it differs in the sequence of 
the fragments in the chain. In particular, analysis of the TOCSY 
spectrum showed a clear correlation of the methylene at H 2.27 (H2-
31) in fragment b'' with the -carbonyl methylene at H 2.52 (H2-28) 
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in partial structure c according to the location of the keto group in 
proximity of the bis propargylic alcohol as in fulvyne C (14). Thus 
fulvyne E (16) was the 37-dehydroxy derivative of 14.  
Last four compounds, fulvynes F-I (17-20), were all 
characterized by the lack of a hydroxyl group in fragment e, showing 
a diol moiety close to propargylic acid residue (fragment e') (Figure 
13). The molecular formula C47H72O11 of fulvyne F (17) was deduced 







H NMR data of 17 (Table 9 and 10) were quite 
similar to those of fulvyne A (12). Careful analysis of 2D NMR 
spectra and in particular of both COSY and TOCSY spectra of 17 
confirmed the presence of the same sequence of fragments a, b', d, 
and c as fulvyne A, whereas a difference was detected in the terminal 
fragment containing the propargylic acid unit missing in one of the 
three hydroxyl groups. Thus fulvyne F (17) was the 6-dehydroxy 
derivative of fulvyne A (12). 
Fulvyne G (18) was isomeric with fulvyne F (17). The NMR 
spectra displayed strong similarities with those of co-occurring 
fulvyne C (14) except for the spin system in the terminal acid part. As 
17, fulvyne G was characterized by the presence of a di-hydroxyl 





The molecular formula of fulvyne H (19) was deduced as 
C48H76O9 from the sodiated molecular ion at m/z 819.4990 in the 
HRESIMS. The spectroscopic data of 19 (Table 9 and 10) clearly 
evidenced that it was lacking in both the ketone and 6-OH groups, 
whereas the remaining part was identical with fulvyne D (15). Thus, 
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the alkyl chain connecting partial structures d and e' contained an 
additional methylene unit with respect to all other co-occurring 
fulvynes. 
Finally, fulvyne I (20) had a molecular formula C47H72O10 as 
deduced from the sodiated molecular ion peak at m/z 819.4917. 
Comparison of NMR data of compound 20 with those of fulvyne E 
(16) indicated the presence of the same fragment sequence a, b", c, 
and d, whereas the terminal residue was constituted by fragment e' 
characterizing fulvynes F-H (17-19). 
3.1.3. Stereochemical assignment 
The relative configuration of contiguous chiral carbons of 
fulvynes as well as of isolated carbinol centres remained unassigned. 
Any attempt to obtain suitable derivatives for a stereochemical 
analysis were unsuccessful due to a rapid degradation of the 
compounds under different reaction conditions. Even the simple 
acetylation conducted under mild conditions resulted in the 
decomposition of the starting material.  
 
3.1.4. Biological and ecological activities evaluation 
Due to the antimicrobial activity directed mainly against the 
gram positive B. subtilis of the butanol extract, pure isolated 
compounds were tested in a more specific assay on a chloramphenicol 
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resistant B. subtilis strain (PY79), showing a good activity against this 
strain (Table 11). Fulvynes were tested also on a gram-positive human 





Cytotoxic activity has been reported for polyacetylenes from 
sponges,
78
 thus the main metabolite was also subjected to 
antiproliferative assays. In particular, fulvyne C (14), tested on 
different tumour cell lines (C6, H9c2, HeLa, 3T3-L1), showed 
selectivity for mouse pre-adipocyte cells line 3T3-L1, being active 





CHAPTER 4: Phylum Mollusca 
 
Molluscs represent the largest marine phylum comprising 
about 23% of all marine organisms. Among them the subclass 
Opisthobranchia is one of most interesting groups from a chemo-
ecological point of view. Species of this subclass are recognized to 
posses secondary metabolites with an extraordinary structural 
diversity. Opisthobranchs are marine molluscs apparently unprotected 
by physical constraints of a shell which is either reduced or 
completely absent in the adults. In spite of this, they are rarely victims 
of predators. In fact, they have elaborated a series of defensive 
strategies, which involve cryptic behaviour and use of chemicals. 
Sometimes, protective substances are accumulated in the anatomical 
structures located in regions of the body most exposed (mantle dermal 
formations),
92,93
 or appendices (cerata) that the organisms detach 
themselves in case of danger.
94, 95
 
Another defensive strategy consists in the use of non-toxic 
compounds, but active as alarm pheromones.
96
 These substances are 
alarm signals, which are issued by an individual in case of predator’s 
attack, indicating to the other members to avoid the dangerous area. 
An additional alarm signal is represented by the colour of the animals 
(warning colouration). Marine slugs are often very colourful. The 
brilliant colours warn potential predators of the existence of another 
primary defensive mechanism such as unpalatability due to repellent 
or toxic molecules (aposematism).  
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The great variety of chemicals in opisthobranchs is mainly 
derived from food.
97
 It has been proven for some opisthobranch 
species the ability to make biosynthetic modifications on substrates 
sequestered from their prey. These chemical transformations often 
result in considerable variation in the toxicity of the processed 
compounds. Further, at the highest levels in the evolutionary scale, 
there are some species able to synthesize their chemical weapons de 
novo from simple precursors.
97
  
The study of opisthobranch molluscs and their chemicals has 
led to the isolation of several bioactive molecules. A representative 
example is the alkaloid jorumycin, which was isolated from the 
defensive mucous secretion of the nudibranch Jorunna funebris.
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Jorumycin showed antimicrobial activity against Bacillus subtilis and 
Staphylococcus aureus and cytotoxic activity on different tumour cell 
lines at low concentration.
99
 PM-104 – trade name Zalypsis® - is an 
antitumor derived from jorumycin, that is currently in phase II clinical 
trial for the treatment of endometrial and uterine cervix cancers by 




Figure 14. Jorunna funebris and Zalypsis® 
 
According to different authors,
100-102
 opisthobranchs are 
divided into a number of orders from 8 to 9 being however 
sacoglossans and nudibranchs the two largest groups.  
Opisthobranchs can be either herbivorous (such as 
sacoglossans) or carnivorous (such as nudibranchs). They have the 
extraordinary capability to create new chemistry through either bio-
accumulation of selected metabolites from their dietary sources, bio-
transformation of dietary compounds , or de novo bio-synthesis. A 
fascinating aspect of the biology of opisthobranchs is related to their 
gradual evolution from a shelled snail to shell-less slug. Sacoglossans 
include both shelled and shell-less forms, whereas nudibranch species 
are all completely naked. The study of these animals offer 









4.1. Placida dendritica 
 
Placida dendritica is a species of the 
order Sacoglossa, belonging to Limapontioidea 
superfamily.  
Members of the order Sacoglossa 
display a complete evolutionary series from shelled molluscs, with a 
large or reduced shell, to shell-less species.
104
 Chemical studies, 
carried out on both shelled and shell-less sacoglossans, have resulted 
in the isolation of sesquiterpenoids and diterpenoids, sequestered from 
green algae and either accumulated or chemically modified, as well as 
polypropionates biosynthesized de novo.  
Limapontioidean sacoglossans are shell-less species 
characterized by a series of dorso-lateral appendages, named cerata, 
which can be, more or less easily, autotomized. The dorsal surface of 
this animal is bright green due to the abundant concentration of 
chloroplasts in the branches of the digestive gland.  
The chemistry of limapontioidean sacoglossans is 
characterized by pyrone-containing compounds.
105 
These metabolites, 
which are formally originated by a polyketide pathway, are associated 
with specific functions of molluscs, since they may act as mediators in 
tissue regeneration and chemical defense.
105
 Most of these propionates 
are biosynthesized de novo by the sacoglossans, although such 





The Mediterranean mollusc P. dendritica has been reported to 
possess a number of regular and irregular propionates, named 




In this study, we have analyzed specimens of P. dendritica, 
which were collected in the Indian Ocean. Three known metabolites, 
cyercenes 2-4, previously reported from Mediterranean Cyerce 
cristallina,
107
 have been isolated and identified by comparison of their 




The polypropionate origin of cyercenes and their de novo 
biosynthesis from 
14
C-propionic acid had been demonstrated in C. 
cristallina by in vivo incorporation experiments.
107,110
 Cyercenes were 
also found to have a different distribution in mantle, cerata and 
mucous secretion of the mollusc whereas they were absent in the 
digestive gland, as it was expected from their de novo biosynthetic 
origin. The anatomical compartmentalization of Cyerce 
polypropionates suggested their possible involvement in the mollusc 
defensive mechanisms, as well as in regenerative processes of cerata. 
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Interestingly, a subsequent study sets out a possible 
photochemical link between cyercenes and placidenes, showing that 
placidene A and isoplacidene A are produced in vitro from cyercene 




Figure 15. Photoreactions of cyercene A 
 
However, the suggested hypothesis of the origin of placidenes 
from a photorearrangement in vivo of cyercene-like precursors appears 
not plausible in consideration of the fact that no sacoglossan species 
has been reported to contain both series of compounds. 
 
4.1.1. Isolation procedure 
The mollusc P. dendritica (86 individuals), collected in the 
Indian Ocean, was treated following a standard procedure to obtain 
separately the extracts of the external and the internal part. In 
particular, the external extract was obtained by soaking the whole 
specimens in acetone bath for few minutes. By this procedure, 
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lipophilic metabolites mainly located in the mantle and in other 
external parts of the animal are extracted. Then, the solvent was 
separated from the animals, filtered and evaporated in vacuum to give 
a residue, which was subsequently extracted with Et2O. This extract 
(ca. 56 mg) was chromatographed on a silica gel column by eluting 
with a gradient system of light petroleum ether/Et2O. The fractions 
containing polypropionates were further purified on RP-HPLC to give 
known cyercene 2-4, the structure of which is characterised by an -
pyrone moiety. These compounds were identified by comparison of 
spectroscopic data with the literature.
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4.1.2. Biological and ecological activities evaluation 
Due to the selective location of cyercenes in the external part 
of C. cristallina, it was suggested a defensive role for these 
metabolites which, indeed, were showed to possess a significant 
ichthyotoxic activity.
107 
An analogous ecological role could be 
hypothesised also for P. dendritica. 
Based on the consideration that ecologically relevant 
molecules often show different bioactivities, cyercene 4, the main 
metabolite isolated, was tested on different human cancer cell lines 
(Hs683, U373, U251, A549, MCF7, SKMEL28, PC3) to evaluate in 
vitro growth inhibitory concentration, through the MTT colorimetric 
assay. In the same test, the related -pyrone aplysiopsene A, which 
had been previously isolated from the limapontioidean sacoglossan 
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Aplysiopsis formosa, in the frame of my degree thesis experimental 
work, 
114
 was also assayed. 
These two molecules are structurally related. They differ only 
in the position of the methyl group on the pyrone moiety (C-5 or C-3) 
and in the length of the alkyl chain (figure 16). 
 
Figure 16. -pyrones from limapontioidean sacoglossans. 
However, these structural differences seem to strongly 
influence the biological activity. Aplysiopsene A displays significant 
in vitro growth inhibitory activity on various cancer cell lines, while 
cyercene 4 displays weak activity (Table 13). Further studies are 






4.2. Peltodoris atromaculata  
Peltodoris atromaculata 
belongs to the suborder Doridina, the 
largest nudibranch group (commonly 
known as “dorids”). 
Dorids containing the most varied species of nudibranchs
102 
are 
often brilliantly coloured. Most of them are sponge-feeders and an 
high specialization of feeding upon sponges is recorded for several 
members of this group. Consequently, the chemistry of dorids is 
strictly related to that of the sponge diet from which the molluscs 
derive their secondary metabolites and this is essential to understand 




Previous chemical studies conducted on the nudibranch P. 
atromaculata have displayed the ability of this mollusc to accumulate 
in the digestive gland a plethora of polyacetylenes compounds, 
petroformynes, mainly derived from its prey, the sponge Petrosia 
ficiformis.
116,82
 In this study, we have analyzed specimens of the 
Mediterranean P. atromaculata, which were observed grazing on 








Very interestingly, a preliminary chromatographic analysis of 
the lipophilic extract of both the nudibranch P. atromaculata and the 
sponge H. fulva revealed a similar secondary metabolite pattern. In 
particular, the chemical analysis of the mollusc extract led us to isolate 
and to characterize four new polyacetylenes, named fulvyne 1-4 (21-
24), closely related to fulvinol, the polar polyacetylenic component of 
Reniera (=Haliclona) fulva from Spanish coasts, as well as renierines, 
short-chain acetylenic compounds previously described from the same 
animal collected off the Bay of Naples. 
It has never been observed any species other than P. 
atromaculata feeding on either of the two sponges. Any predator on 
P. ficiformis and H. fulva has to deal with the numerous secondary 
metabolites that have been detected in these sponges. It is surprising 
that P. atromaculata is believed to feed exclusively on these sponges, 
which are some of the most cytotoxic Mediterranean sponges. 
Petroformynes and fulvinol display linear alkyl chains of 46 carbons 
with a characteristic 1-yn-3-ol-4-ene moiety at each terminus, and 
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were shown to be cytotoxic in bioassays.
79,80
 These metabolites have 
not been detected in any other Mediterranean sponges. Thus, 
Peltodoris is highly specialized on the two only Mediterranean 
sponges that contain these specific polyacetylenes.  
 
4.2.1. Isolation procedure 
P. atromaculata (3 individuals) was found grazing on the 
sponge H. fulva in Pizzaco off Procida (Italy). The mollusc was 
collected and dissected into internal glands and mantle. The two 
tissues were separately extracted in acetone. After filtration and 
evaporation of the organic solvent in vacuum, the aqueous residues 
were subsequently extracted with Et2O to get about 15 mg of mantle 
extract and 62 mg of internal glands extract. Preliminary TLC analysis 
showed a different metabolite pattern for the two extracts. In 
particular, a series of metabolites, most likely of dietary origin, were 
observed to be concentrated in the extract of internal part also 
including the digestive gland. This extract was chromatographed on a 
Sephadex LH-20 column in CHCl3/MeOH, and then further 
fractionated on silica gel column by eluting with a gradient system of 
light petroleum ether/Et2O. Preliminary 
1
H NMR analysis revealed the 
present of a mixture of polyacetilenes that was further purified on RP-
HPLC with MeOH to afford, in order of retention time, pure fulvyne 
1-4 (21-24), together with some known renierines. The new molecules 
were recognized also in the extract of the sponge H. fulva, from which 
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were also purified. The structures were elucidated by interpretation of 
spectral data. 
 
4.2.2. Structure determination 
The NMR spectra of all new compounds 21-24 were 
reminiscent with that of fulvinol and, with regards to terminal 
moieties, with those of petroformynes. 
Fulvyne 1 (21) had a molecular formula C46H72O2 deduced by 
ESIMS [m/z 679 (M+Na)
+
] and HRFABMS [m/z 663.5320 (M+Li-
H)
+
]. Both the 
1
H- and the 
13
C-NMR spectra contained a smaller 
number of signals than those expected from the molecular formula, 
suggesting a highly symmetric structure. This implied that each 
resonance of the spectrum was attributable to two magnetically 
equivalent nuclei. The 
1
H NMR spectrum contained a singlet at  3.20 
attributable to the terminal acetylenic protons, a doublet at  6.18 
(J=15.7 Hz, 2H, H-4 and H-45) that correlated in the COSY spectrum 
with a signal under the solvent at  7.25 (Figure 17). The coupling 
constant of 15.7 Hz indicated an E geometry for the double bond 
belonging to the terminal residue. The remaining signals at  1.98-
2.08,  1.45-1.55 and  1.32-1.38 were assigned to an envelope of 




Figure 17: 1H NMR spectrum of fulvyne 1 (21) 
 
The presence in the IR spectrum of two bands at 1650 and 
2098 cm
-1
 were attributed to a conjugated carbonyl group and of a 
triple bond, respectively. Moreover, the occurrence in the 
13
C-NMR 
spectrum of the resonances at  177.8 (s, C-3 and C-44), 155.9 (d, C-5 
and C-42), 131.9 (d, C-4 and C-43) and 78.8 (d, C-1 and C-46) 
suggested that fulvyne 1 contained two (E) 1-yn-3-oxo-4-ene 
moieties. These residues accounted for six of the nine degrees of 
unsaturation indicated by the molecular formula. The three remaining 
unsaturations were attributed to three Z double bonds as indicated by 
the 
1





at  130.0, 129.8, and 129.7. The three double bonds along the chain 
were located at C-19, C-25 and C-31 by analysis of the fragmentation 
in FABMS/MS.  
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Fulvyne 2 (22) had a molecular formula C46H74O2, deduced 
from ESIMS [m/z 681 (M+Na)
+
] and HRFABMS [m/z 665.6318 
(M+Li-H)
+





spectra of fulvyne 2 were very similar to those of fulvyne 1. The only 
difference was due to the presence of a carbinol function rather than 
the carbonyl group in one of the two terminal moieties of the molecule 




H COSY spectrum of 22 disclosed a 
broad doublet at  4.83 (J=6.2) that correlated both with a double 
doublet at  5.60 (dd, J=15.7, 6.2 Hz), in turn coupled with the signal 
at  5.91 (dt, J=15.7, 7.3 Hz), and with a long range coupled alkyne 
signal at  2.56. This was consistent with an (E)-1-yn-3-hydroxy-4-
ene-moiety (fragment a, Figure 19).  
The presence of a hydroxy group was further confirmed by the 
IR band at 3300 cm
-1
. Furthermore the 
13
C NMR spectrum showed 
signals at C-44)(C-43) and 134.9 (C-42) in agreement 
with the data reported in literature for petroformynes and fulvinol that 
possess the same terminus. The pattern of fragmentation observed in 
FABMS/MS of fulvyne 2 was the same as fulvyne 1 indicating the 
same position for the inner double bonds. 
The ESIMS and HRFABMS spectra of fulvyne 3 (23) (ESIMS 
[m/z 683 (M+Na)
+
] and HRFABMS [m/z 667.5205 (M+Li-H)
+
]) 
suggested the molecular formula C46H76O2. The 
1
H NMR of 
compound 23 strongly resembled that of known fulvinol. However, 
analysis of NMR and FABMS/MS data suggested that it differed from 
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fulvinol in the location of the inner double bonds. In particular the 
same framework of signal in FABMS/MS - as in fulvynes 1-3 – aided 
us to located the inner double bonds as depicted in formula. 
 
 Figure 18: 1H NMR spectrum of fulvyne 2 (22) 
 
Fulvyne 4 (24) had the molecular formula C46H74O3, as 
deduced from ESIMS [m/z 699 (M+Na)
+
] and HRFABMS [m/z 
683.5065 (M+Li-H)
+
], suggesting the presence of an additional 
hydroxy group as well as a further unsaturation with respect to 
fulvyne 3. The 
1
H NMR spectrum showed two terminal alkyne 
protons at  2.56 (d, J=2.3 Hz, H-1) and 2.58 (d, J=2.2 Hz, H-46) 
(Figure 20). The little difference observed in the chemical shift of the 
two protons was ascribed to the presence of an additional hydroxyl 
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Figure 19: fragments a-b in fulvynes 
In particular, H-1 ( 2.56) was long-range coupled to the 
alcoholic proton at  4.83 (br d, J=5.5 Hz, H-3) which was in turn 
correlated with an olefinic proton at  5.60 (dd, J=5.5, 15.0 Hz, H-4). 
This latter proton was connected to the vicinal olefinic proton at  
5.92 (dt, J=6.4, 15.0, H-5) correlating with a methylene signal at  
2.00 (fragment a). On the other hand, the alkyne proton at  2.58 (H-
46) was long–range coupled with the signal at  4.90 (br d, J=4.5 Hz, 
H-44). This carbinolic methine was connected to the olefinic proton at 
 5.82 (dd, J=5.5, 15.4 Hz), which was coupled to the vicinal olefinic 
proton at  5.96 (dd, J=5.0, 15.4). This latter signal had a cross-peak 
with the alcoholic proton at  4.17 (H-41) that was in turn correlated 
with the methylene signal at  1.40 (fragment b). Analysis of the 
13
C 
NMR spectrum and 2D NMR experiments confirmed the assignment 
of the two terminal moieties whereas the FABMS/MS suggested the 
position of the inner double bonds as depicted in structure 24. 
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 Figure 20: 
1
H NMR spectrum of fulvyne 4 (24) 
 
4.2.3.  Stereochemical assignment 
With the aim to establish the absolute configuration of 
fulvynes 1-4, the Mosher method was applied on compound 23. 
Fulvyne 3 was treated with (R)- and (S)-MTPA chlorides to get the (S) 
and (R)-MTPA esters 23a and 23b. The(Sester-Rester) values 
observed for the protons close to the hydroxyl groups at C-3 and C-44 
indicated the S configuration of the two chiral centres (Figure 21). 
 
 
Figure 21: Chemical shifts differences (Sester-Rester) between (S)- and (R)-
MTPA derivatives of compound 23 
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Based on biogenetic considerations, the S configuration was 
suggested for the carbinol centres of the other co-occurring fulvynes.  
 
4.2.4. Biological and ecological activities evaluation 
Sponge-derived acetylenes and polyacetylenes are widely 
recognized for their diverse and potent bioactivities. In fact, they 
exhibit potent antimicrobial, antiviral, cytotoxic, RNA-cleaving, and 
enzyme-inhibitory activities as well as brine-shrimp lethality.
79,82,117-
127 
In addition, some of these compounds have important ecological 
functions, including metamorphosis-inducing and antifouling effects 
against larvae of benthic invertebrates.
124
 
The in vitro growth inhibitory activity of fulvyne 1-4 on 
various human cancer cell-lines is presently under investigation. 
 
4.3. Aldisa andersoni  
Aldisa andersoni is a dorid 
nudibranch that has never been studied 
to date. Chemical investigations have 
been conducted for related species of 
genus Aldisa resulting in the isolation of a steroid from A. 
smaragdina
128a 





 The nudibranch here analysed has been collected in the Indian 
Ocean. The chemical study has led to the isolation of three novel 
chlorinated phenylpyrrolyloxazoles, compounds 25-27. Their 
structures were strongly reminiscent to known phorbazoles, 
metabolites previously isolated from the sponge Phorbas aff. 
clathrata
129





4.3.1. Isolation procedure 
Because of their small size, 6 individuals of A. andersoni were 
not dissected, but first immersed in acetone and submitted to 
ultrasound vibration for 1 min. Only the metabolites present in the 
mantle (external part) were extracted by this procedure. The solvent 
was removed and the animals were homogenised with a pestle and 
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again treated with acetone, so as to extract the digestive gland content 
(internal part). 
After filtration and evaporation of acetone in vacuum, the 
residues were subsequently extracted with Et2O to obtain two ethereal 
extracts. The TLC chromatographic analysis showed similar 
secondary metabolite pattern for the two parts characterised by the 
presence of a series of UV-sensitive compounds. However, these 
molecules, clearly present in the digestive gland, were observed to be 
accumulated in the external part of the animal. Thus, the mantle 
extract (about 20 mg) was chromatographed on RP-HPLC 
(MeOH/H20 gradient), to afford six pure compounds: phorbazoles D 
(0.7 mg), E (25, 4.9 mg), A (4.0 mg), B (2.5 mg), F (26, 1.1 mg) and 
G (27, 0.8 mg).  
The identification of known phorbazoles A, B and D was made 




C NMR) with the 




4.3.2. Structure determination 
Analysis of the NMR spectra of novel compounds 25-27, 
which we named phorbazoles E, F and G, respectively,  revealed a 
close structural relationship with known phorbazoles. Basically, the 
structural differences among them relies on the number and on the 
location of chlorine atoms.  
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Phorbazole E (25) had a molecular formula C13H8Cl2N2O2 
deduced by LCMS [m/z 295 (M+H)
+
] and HRESIMS [m/z 316.9849 
(M+Na)
+
], that showed a proper cluster for two Cl atoms. The proton 
NMR spectrum of 25 exhibited only four sp
2
 signals at (d, 
J=2.8 Hz, 1H), 6.93 (d, J=8.7 Hz, 2H), 6.97 (d, J=2.8 Hz, 1H) and 
7.81 (d, J=8.7 Hz, 2H), suggesting two separated spin systems. This 
implied that the two chlorine atoms were located in both the pyrrole 
and the oxazole rings. The 
13
C NMR spectrum was more informative. 
Indeed, it contained 11 sp
2
 carbon signals in the range of 111.8-159.6 
ppm (Table 14). The two dimensional NMR experiments aided us to 
fully characterise the molecule. In particular, HMBC experiments, 
recorded with J=5 Hz and J=10 Hz, were crucial to attribute the 
quaternary carbons and to assign the structure as depicted in formula 










Table 14:  
NMR spectroscopic data
a,b
 in CD3OD for phorbazoles E-G (25-27). 
a Bruker 300 MHz and 600 MHz, b assignement aided by HMBC 
 
The LCMS analysis of phorbazole F (26) showed peaks at m/z 
343 (M+H)
+
 with the typical cluster due to the presence of three Cl 
atoms. The HRESIMS spectrum indicated the molecular formula 
C14H9Cl3N2O2 as deduced from m/z 365.2582 [(M+Na)
+
]. The NMR 
spectra of 26 showed proton and carbon resonances very similar to 
those of phorbazole A, indicating the same substitution pattern in the 
heterocycle rings. The only difference was in the presence of a 3H 
signal resonating at H 4.0 (C 38.4), which was attributed to a methyl 
linked at the pyrrole nitrogen. Thus phorbazole F was the 1-N-methyl 
phorbazole A. 
Phorbazole G (27) was obtained in very small amount. The 





 with a cluster consistent with four Cl atoms. Accordingly, the 
HRESIMS showed the molecular formula C13H6Cl4N2O2 [m/z 
384.9183 (M+Na)
+
]. In agreement with MS data, the 
1
H NMR 
spectrum exhibited only the two doublet signals due to the 4-
hydroxyphenyl moiety, indicating that all other positions on the 
pyrrole and oxazole rings were substituted.  
4.3.3. Biological and ecological activities evaluation 
Even phorbazoles are most likely sequestered from the sponge 
diet, the selective accumulation of these molecules in the external part 
of the mollusc seems to suggest their involvement in the chemical 
defensive mechanisms of A. andersoni. Unfortunately, the small 
quantity available for each phorbazole metabolite prevented the 
performing of suitable ecological tests to demonstrate the possible 
defensive role of phorbazoles.    
However, based on the consideration that ecologically relevant 
molecules often show different bioactivities, main compounds 
phorbazoles E and F (25, 26) were tested on the cell lines C6 of 
glioma to evaluate the cytotoxic activity. The cell were treated for 48 
h with different concentration of the metabolite (25, 50 , 100 and 200 













Phorbazole E (25) was active at a concentration 100 µM 
whereas  phorbazole F (26) was not active. 
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CHAPTER 5: Experimental Section 
5.1. General methods  
5.1.1. Biological material  
The biological material analyzed in this PhD work was 
sampled during different research campaigns. The samples were 
collected using SCUBA, within international collaborative 
programmes between the Institute of Biomolecular Chemistry of 
National Council Research of Pozzuoli and foreign Institutes. The 
material was collected at a depth between 0 and 40 m and suddenly 
frozen at -20 °C.  
5.1.2. Extraction and isolation  
The biological material was extracted following a standard 
procedure (figure 22). In particular, the sample was crushed and 
sonicated while submerged in a minimum volume of Me2CO. The 
organic solvent was removed, filtered through paper, then evaporated 
under reduced pressure to give an aqueous residue which was then 
partitioned firstly with Et2O and secondly with BuOH. The organic 
layers were removed, dried with anhydrous Na2SO4, and concentrated 









Figura 22: Extraction procedure 
 
Each extract was analyzed by Thin Layer Chromatography 
(TLC) and 
1
H NMR. Thin layer chromatography (TLC) was 
performed by spotting solutions of analyte onto TLC plates using a 
micropipette. After sufficient time to allow the analyte to dry, the TLC 
plate was placed into a sealed chamber containing the mobile phase. 
Upon completion of development, the TLC plate was removed and 
visualized under 245 nm UV light, then stained using ceric sulfate 
stain. The stained plates were visualized after heating via a hot air 
stream. Normal phase thin layer chromatography (NP-TLC) analyses 
were performed using precoated, glass-backed silica gel plates 
(Kieselgel 60 F254, 0.25 mm thickness, Merck). Reversed phase thin 
layer chromatography (RP-TLC) analysis were performed using C18-
modified precoated, glass-backed silica gel plates (RP-18 F254, 0.25 
mm thickness, Merck). 
Thus the extracts were separately fractioned by the suitable 
chromatographic techniques. Silica-gel chromatography was 
performed using pre-coated Merck F254 plates and Merck Kieselgel 60 
powder. Sephadex LH-20 was from Amersham Pharmacia Biotech 















Shimadzu liquid chromatograph LC-10AD equipped with an UV 
SPD-10A wavelength detector or HPLC Waters 501 pumps with a 
refractometer detector. Analytical (250 x 4.6 mm) and semipreparative 
(250 x 10 mm) columns (Kromasil C18 and Supelco RP-amide) used 
in RP-HPLC were from Phenomenex and Supelco. 
5.1.3. Spectroscopic data 
Optical rotations were measured on a Jasco DIP 370 digital 
polarimeter. IR spectra were recorded on a Biorad FTS 155 FT-IR 
spectrophotometer. NMR experiments were conducted at ICB-NMR 
Service Centre. 1D and 2D NMR spectra were acquired in CDCl3 or 
CD3OD, DMSOd6 (shifts are referenced to the solvent signal) on a 
Bruker Avance-400 operating at 400 MHz, using an inverse probe 
fitted with a gradient along the Z-axis and a Bruker DRX-600 
operating at 600 MHz, using an inverse TCI CryoProbe fitted with a 
gradient along the Z-axis.
13
C NMR spectra were obtained on a Bruker 
DPX-300 operating at 300 MHz using a dual probe and on Bruker 
DRX-600MHz. High and low resolution LR and HRESIMS were 
recorded on a Micromass Q-TOF MicroTM coupled with a HPLC 
Waters Alliance 2695. The instrument was calibrated by using a PEG 
mixture from 200 to 1000 MW (resolution specification 5000 FWHM, 
deviation <5 ppm RMS in the presence of a known lock mass). GC-
MS was carried out on an ion-trap MS instrument in EI mode (70eV) 
(Thermo, Polaris Q) connected with a GC system (Thermo, GCQ) by 
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a 5% diphenyl (30 m x 0.25 mm x 0.25 um) column using helium as 
gas carrier. 
 
5.2. Experimental section for Chapter 1  
 
5.2.1. Alcyonium antarcticum 
 
5.2.1.1. Biological material: The soft coral Alcyonium antarcticum 
was collected in January 2002 during the XVII Italian Campaign in 
Antarctica off Terra Nova Bay (Stazione M. Zucchelli) and 
immediately frozen and transferred to ICB. The soft coral was 
classified by Dr Stefano Schiapparelli (Dipartimento per lo Studio del 
Territorio e delle sue Risorse, University of Genova). A voucher 
specimen is stored at ICB under the code AlcyAA. 
 
5.2.1.2. Extraction and isolation: The frozen A. antarcticum (dry 
weight, 112 g) was chopped and then extracted exhaustively with 
Me2CO (400 mL x 4) using ultrasound. After filtration and 
evaporation in vacuo of the organic solvent, the residue was 
subsequently extracted with Et2O (200 mL x 4) and n-BuOH (100 mL 
x 4). The evaporation of Et2O and n-BuOH extracts gave two oily 
residues (3.8 g and 2.2 g, respectively). The ethereal extract was 
subjected to silica-gel column chromatography using as eluent a 
gradient of light petroleum and Et2O, CHCl3 and finally MeOH to 
give five fractions: fr. I (550 mg), fr. II (20 mg), fr. III (890 mg), fr. 
IV (810 mg), and fr. V (400 mg). Fraction I was subjected to silica gel 
column purification (light petroleum/diethyl ether gradient) to give the 
known 4-methyl-2-[(E)-2-methyl-6-methyleneocta-2,7-dienyl]-furan 
(50 mg) and deacetoxy-alcyonicene (2, 0.5 mg). Fr. II was further 
purified by HPLC n-phase (n-hexane/EtOAc, 95:5, Kromasil 
analytical column, flow rate 1 mL/min) to give pure alcyonicene (1, 6 
mg). Fr III was purified by silica-gel column chromatography yielding 
45 mg of pregnenolone-3-acetate. Fr.IV gave, after filtration on a 
Sephadex LH-20 column, pregnenolone (1.0 mg). Finally, the more 
polar fraction (V) was subjected to silica-gel column chromatography 
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and TLC to afford pure pukalide (7.0 mg). The known compounds, 4-
methyl-2-[(E)-2-methyl-6-methyleneocta-2,7-dienyl]-furan, 3-
acetylpregnenolone, pregnenolone and pukalide were identified by 




C NMR, MS and 
[α]D) with those reported in the literature. 
 
5.2.1.3. Biological assays: Ichthyotoxicity tests against the mosquito 
fish, Gambusia affinis (Baird & Girard, 1853), were conducted 
according to literature procedures.
36
 All the isolated metabolites were 
assayed at 10 ppm. Feeding-deterrence tests against gold fish, 
Carassius auratus, were conducted according to literature 
procedures.
35
 All the compounds were assayed at 50 μg/cm2.  
The antimicrobial activity against Escherichia coli DH5a and 
Staphylococcus aureus ATCC6538P was determined. Activity was 
studied by the broth microdilution method.
38
 The test was carried out 
in a 96-well, flat-bottomed, microtitration plate. Plates were incubated 
at 37°C without shaking, and reading was performed following 24 h of 
incubation by optical density (OD) determination with a 
spectrophotometer; plates were shaken for 5 min and the OD values at 
492 nm of each well were read with a microtiter plate reader 
(Thermolabsystems Multiskan MK3). All experiments were 
performed in triplicate at concentration of 100 μg/mL. 
 
Alcyonicene (1): 6 mg (0.16%), [α]D꞊ +33.9 (c 0.6, CHCl3), Rf : 0.5 
(light petroleum ether -Et2O, 95:5), IR (liquid film): 3100, 2938, 2878, 




H NMR and 
13
C NMR: Table 3, 
HRMS-ESI: m/z [M + Na
+
] calcd for C17H26O2Na: 285.1831; found: 
285.1824. 
Deacetoxy-alcyonicene (2): 0.5 mg (0.013%), [α]D꞊ -2.8 (c 0.05, 
CHCl3), Rf : 0.1 (light petroleum ether), IR (liquid film): 3100, 2938, 
2878, 1645, 1445, 1245, 892 cm
-1
, GC-EIMS (EI, 70 eV): m/z (%) = 
204.2 [M
+







5.2.2.  Parazoanthus axinellae 
 
5.2.2.1. Biological material: The sea anemone Parazoanthus 
axinellae was collected in June 2008 from Prof. Vassilios Roussis and 
assistants. A voucher specimen is stored at the University of Athens 
under the code PAX. 
 
5.2.2.2. Extraction and isolation: The dry P. axinellae ( 118 g) was 
extracted with CH2Cl2/MeOH 1:1 (500 mL x 3). After filtration and 
evaporation in vacuo of the organic solvent, half of the extract (10 g) 
was subjected to Vacuum Liquid Cromatography (VLC), using 
reverse phase silica-gel column chromatography and a gradient of 
H2O and MeOH to give 13 fractions. Half of Fraction I (1 g) was 
subjected to Medium Pressure Liquid Cromatography (MPLC), using 
reverse phase silica gel column and a linear gradient of H2O(+0.1% 
TFA)/MeOH from 9:1 to 4:6 in 240 min, and finally H2O(+0.1% 
TFA)/MeOH 2:8 to give 12 fraction. Fr. X was further purified by 
HPLC RP-phase (H2O/MeOH/TFA, from 24.9:75:0.1 to 49:50:0.1 in 
50 minutes, RP-amide semipreparative column, flow rate 2 mL/min) 
to give pure parazoanthine F (3, 1.3 mg) and G (4, 1.6 mg), along with 
parazoanthines A-E. The known compounds were identified by 




C NMR, MS and 
[α]D) with those reported in the literature. 
 
5.2.2.3. Biological assays: The antiproliferative activity were tested in 
vitro on seven human cancer cell lines (Hs683, U373, U251, A549, 
MCF7, SKMEL28, PC3), using the MTT colorimetric assay.  
The in vitro Scratch Wound Assay were performed using different cell 
lines. Mouse B16F10 melanoma, and human A549 non-small-cell 
lung cancer (NSCLC) and Hs683 glioma cells were grown until 
confluence and then a scratch has been performed as detailed in 
Mathieu V et al. 2005.
48
 The cancer cells have been cultured in 
presence of 10% fetal calf serum. The % of the wound healing process 
has been quantitatively determined as detailed in Mathieu V et al. 
2005.
48
 All experimental conditions were performed as tetraplicates, 
excepted for A549 NSCLC cells that was performed in triplicates.  
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The antimicrobial activity against Escherichia coli DH5a and 
Staphylococcus aureus ATCC6538P was determined. Activity was 
studied by the broth microdilution method.38 The test was carried out 
in a 96-well, flat-bottomed, microtitration plate. Plates were incubated 
at 37°C without shaking, and reading was performed following 24 h of 
incubation by optical density (OD) determination with a 
spectrophotometer; plates were shaken for 5 min and the OD values at 
492 nm of each well were read with a microtiter plate reader 
(Thermolabsystems Multiskan MK3). All experiments were 
performed in triplicate at concentration of 100 μg/mL 
Parazoanthine F (3): 1.3 mg, UV (MeOH) max (log ) 210 (7.40), 
281 (7.41); 
1
H NMR and 
13
C NMR in CD3OD: Table 4, HRMS-ESI: 
m/z [M + H]
+
 calcd for C15H20N5O3: 318,1488; found: 318,1555. 
Parazoanthine G (4): 1.6 mg, [α]D꞊ +11.4  (c, CH3OH), 
1
H NMR and 
13
C NMR in CD3OD: Table 4, HRMS-ESI: m/z [M + H]
+
 calcd for 
C16H22N5O3: 332,3696; found: 332,2881. 
5.3 Experimental section for Chapter 2  
5.3.1.  Pseudodistoma crucigaster 
5.3.1.1. Biological material: The colonial ascidian P. crucigaster 
Gaill, 1972 was collected in October 2007 off Cala Sgombro (inside 
part) along the Sardinia coasts by G.V. at a depth of -10 m, 
immediately frozen and transferred to ICB. The ascidian was 
classified by Dr. Flavia Greco of Zoologic Department of University 
of Bari. A voucher specimen is stored at ICB under the code ATC. 
 
5.3.1.2. Extraction and isolation: The frozen ascidian P. crucigaster 
(dry weight, 5.2 g) was chopped and then extracted exhaustively with 
Me2CO (400 mL×4) using ultrasound. After filtration and evaporation 
in vacuo of the organic solvent, the residue was subsequently 
extracted with Et2O (200 mL×4) and BuOH (100 mL×4). The 
evaporation of Et2O and BuOH extracts gave two gummy residues 
(0.783 g and 0.976 g, respectively). The ethereal extract was subjected 
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to a silica gel column chromatography using as eluent a gradient of 
light petroleum ether and Et2O, CHCl3 and finally MeOH to give eight 
fractions. Preliminary 
1
H NMR analysis of these fractions evidenced 
that the last fraction (0.207 g) contained a mixture of some interesting 
compounds. Part of this fraction (0.120 g) was first acetylated with 
acetic anhydride in pyridine (2 h, room temperature) to prevent 
degradation of the compounds and then subjected to reverse-phase 
HPLC column chromatography (MeOH/H2O, 8:2; flow 1 mL/min) to 
afford in order of decreasing polarity diacetyl crucigasterin A (5a) (tR 
9.6 min, 1.4 mg), B (6a) (tR 11.2 min, 1.9 mg), C (7a) (tR 15.2 min, 
5.4 mg), D (8a) (tR 25.0 min,3.3 mg), E (9a) (tR 34.0 min, 2.1 mg). 
 
5.3.1.3. Preparation of oxazolidinone derivative (11): In order to 
prepare the oxazolidinone derivative of crucigasterin A (5) the 
diacetyl derivative 5a (1 mg) was treated with NaOH (4 M) at 70 °C 
for 20 h. The free aminoalcohol (0.8 mg, 5) obtained from this 
reaction was then reacted with 1,10-carbonyldiimidazole (3 mg) in 1 
mL of CH2Cl2 and 100 mL of DMF at 0 °C for 19 h under argon 
atmosphere. The solution was extracted with water and the organic 
layer was dried under nitrogen yielding 0.5 mg of the oxazolidinone 
11. 
 
5.3.1.4. Preparation of MTPA esters: Diacetyl crucigasterin 10a 
(2.1 mg) was treated with Na2CO3 in anhydrous MeOH and stirred at 
room temperature overnight. After filtration and evaporation of the 
solvent, the reaction product (10b) was divided into two parts, which 
in turn were reacted with R-(-)-MTPA chloride and S-(+)-MTPA 
chloride, to give the S-(10c) and R-MTPA-(10d)-esters, respectively.  
S-MTPA ester was prepared by treating 1 mg of 10b with 0.005 mL of 
R-(-)-MTPA chloride in dry CH2Cl2 (0.5 mL) with catalytic amount of 
DMAP under stirring for 16 h at room temperature. The ester was 
purified by chromatography in a Pasteur pipette (SiO2, CHCl3).  
R-MTPA ester was prepared by treating 1 mg of 10b with 0.005 mL 
of S-(+)-MTPA chloride in dry CH2Cl2 (0.5 mL) with catalytic 
amount of DMAP under stirring for 16 h at room temperature. The 
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ester was purified by chromatography in a Pasteur pipette (SiO2, 
CHCl3).  
 
5.3.1.5 Biological assays: Antifungal assay was performed by the 
broth macrodilution method following the guidelines of the National 
Committee for Clinical Laboratory Standards (NCCLS) document 
M27-P.26,27 The medium used to prepare the 10× drug dilutions and 
the inoculums suspension was liquid RPMI 1640 with L-glutamine 
(Sigma Aldrich), 0.165 M morpholinopropane sulfonic acid (MOPS) 
and 2% glucose (pH 7.0).28,29 The yeast suspension was adjusted 
with the aid of a spectrophotometer to a cell density of 0.5 McFarland 
(2×108 CFU/ mL) standard at 530 nm and diluted to 1:4000 (50,000 
CFU/mL) in RPMI 1640 broth medium. The yeast inoculum (0.9 mL) 
was added to each test tube that contained 0.1 mL of 10 twofold 
dilutions (256×0.05 mg/mL final) of each compound. Broth 
macrodilution MICs were determined after 48 h of incubation at 35 
°C. MIC was defined as the lowest concentration of the compound 
that completely inhibited the growth of the test organism. The 
antibacterial assay was performed by using the same method as the 
antifungal test, only differing in the assay medium (Luria Bertani 
medium: 10 g/L bactotryptone, 5 g/L bactoyeast, and 10 g/L NaCl, pH 
7.5) and in the incubation temperature (37 °C for 24 h). Crucigasterin 
B (6) and E (9) were tested for antifungal and antibacterial activities, 
exhibiting moderate activity against E. coli and C. albicans, 
respectively. 
 
Diacetyl crucigasterin A (5a). Colourless oil; []D -24.7 (c 0.1, 
CHCl3); []D -20.3 (c 0.03, CH3OH); UV (MeOH) max (3) 230 






C NMR data in Tables 5 and 6; HRESIMS m/z 330.2042 (M+Na), 
calcd for C18H29NO3Na 330.2045.  
 
Diacetyl crucigasterin B (6a). Colourless oil, []D -16.8 (c 0.2, 







C NMR data in Tables 5 and 6; HRESIMS m/z 332.2204 




Diacetyl crucigasterin C (7a). Colourless oil, []D -28.0 (c 0.1, 







C NMR data in Tables 5 and 6; HRESIMS m/z 382.2341 
(M+Na), calcd for C22H33NO3Na 382.2358.   
 
Diacetyl crucigasterin D (8a). Colourless oil; []D -12.1 (c 0.3, 







C NMR data in Tables 5 and 6; HRESIMS m/z 360.2518 
(M+Na), calcd for C20H35NO3Na 360.2515 
 
Diacetyl crucigasterin E (9a). Colourless oil; []D -15.2 (c 0.2, 







C NMR data in Tables 5 and 6; HRESIMS m/z 386.2686 




H NMR (CDCl3)  6.12 (dd, J=15.3, 10.5 Hz, 
H-6), 6.00 (dd, J=15.3, 10.5 Hz, H-7), 5.80 (ddt, J=16.4, 10, 6.5 Hz, 
H-13), 5.65 (ddd, J=15.3, 7.0, 7.0 Hz, H-5), 5.50 (ddd, J=15.3, 7.0, 7.0 
Hz, H-8), 5.0 (br d, J=17 Hz, H-14a), 4.95 (br d, J=10 Hz, H-14b), 
4.17 (m, H-3), 3.62 (m, H-2), 2.48 (m, H2-4), 2.05 (m, H2-9 and H2-
12), 1.38 (m, H2-10 and H2-11), 1.28 (d, J=6 Hz, H3-1); ESIMS m/z 
272 (M+Na)
+
; HRESIMS m/z 272.1628 (M+Na), calcd for 
C15H23NO2Na 272.1621. 
 
Compound 10a. Colourless oil, []D-19.1 (c 0.12, CHCl3); IR (liquid 






C NMR data 
in Tables 5 and 6; HRESIMS m/z 332.2204 (M+Na), calcd for 
C18H31NO3Na 332.2202. 
 
Compound 10c (S-MTPA ester): S-MTPA ester was prepared by 
treating 1 mg of 10b with 0.005 mL of R-(-)-MTPA chloride in dry 
CH2Cl2 (0.5 mL) with catalytic amount of DMAP under stirring for 16 
h at room temperature. The ester was purified by chromatography in a 
Pasteur pipette (SiO2, CHCl3). Selected 
1
H NMR values (CDCl3):  
5.81 (H-13), 5.49 (H-6), 5.25 (H-5), 5.00 (H-3), 4.98 (H-14a), 4.96 
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(H-14b), 4.33 (H-2), 2.28 (H2-4), 2.00 (H2-7 and H2-12), 1.95 
(NHCOCH3), 1.30 (H2-8, H2-9, H2-10 and H2-11), 1.12 (H3-1).  
 
Compound 10d (R-MTPA ester): R-MTPA ester was prepared by 
treating 1 mg of 10b with 0.005 mL of S-(+)-MTPA chloride in dry 
CH2Cl2 (0.5 mL) with catalytic amount of DMAP under stirring for 16 
h at room temperature. The ester was purified by chromatography in a 
Pasteur pipette (SiO2, CHCl3). Selected 
1
H NMR values (CDCl3):  
5.81 (H-13), 5.53 (H-6), 5.32 (H-5), 5.07 (H-3), 4.98 (H-14a), 4.96 
(H-14b), 4.32 (H-2), 2.34 (H2-4), 1.92 (NHCOCH3), 1.30 (H2-8, H2-9, 
H2-10 and H2-11), 1.04 (H3-1). 
 
5.4 Experimental section for Chapter 3  
5.4.1. Haliclona fulva 
5.4.1.1. Biological material: The sponge H. fulva, was collected in 
May 2009 in Punta Pizzaco, Procida Island (Naples) by Dr. G. Villani 
of ICB at a depth of -40 m, and transferred to ICB. A voucher 
specimen is stored at ICB under the code FUL. Three specimens of P. 
atromaculata found grazing on H. fulva were collected as well and 
transferred to ICB under the code DA.  
5.4.1.2. Extraction and isolation: The sponge H. fulva (dry weight, 
42 g) was chopped and then extracted exhaustively with Me2CO (500 
mL×6) using ultrasound. After filtration and evaporation of the 
organic solvent in vacuo, the residue was subsequently extracted with 
Et2O (500 mL×7) and BuOH (650 mL×2). The evaporation of Et2O 
and BuOH extracts gave two gummy residues (1.46 g and 2.48 g, 
respectively). Part of the butanolic extract (1.2 g) was subjected to a 
Sephadex LH-20 column chromatography (35×900 mm) using as 
eluent MeOH, to give eight fractions (I-VIII). Preliminary 
1
H NMR 
analysis of these fractions showed that fraction III (0.228 g) contained 
a mixture of some interesting compounds. An aliquot of this fraction 
(0.120 g) was further purified on RP-Amide semipreparative HPLC 
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column (Supelco, 250 mm×10 mm, 5 mm) with a gradient of 
H2O/MeOH/TFA (from 29:70:0.1 to 100% MeOH, flow 2.0 mL min
-
1
) to afford pure compounds 12 (tR 28.2 min, 4.7 mg), 13 (tR 31.5 min, 
3.1 mg), 14 (tR 33.0 min, 11.5 mg), 15 (tR 39.2 min, 4.2 mg), 16 (tR 
41.0 min, 8.7 mg), 17 (tR 50.0 min, 5.4 mg), 18 (tR 53.8 min, 5.6 mg), 
19 (tR 55.2 min, 2.4 mg) and 20 (tR 57.0 min, 2.9 mg). 
5.4.1.3. Biological assays: Bacterial strain of B. subtilis, 
chloramphenicol-resistant (PY79), E. coli (DH5a) and C. albicans 
were used in the antibacterial tests. The bacteria were grown 
overnight, diluted 1:1000 in 10 mM sodium phosphate buffer (pH 
7.5), and incubated with increasing concentrations of different 
compounds at a density of 4000 colony forming units (CFUs) per mL. 
After 4 h at 37 °C, serial dilutions of each proteinebacteria mix were 
prepared and plated on chloramphenicol (5 g/mL) containing 
medium, and colonies formed after each treatment were determined. 
For each experiment, carried out in duplicate, triplicate assays were 
performed. 
Fulvyne A (12): 4.7 mg, [D +8.2 (c 0.3, CH3OH); UV (MeOH) max 
(log ) 205 (3.38); max (liquid film) 3309, 2925, 2854, 2237, 1696, 






C NMR data in Tables 7 and 8; ESIMS m/z 851 [M+Na]
+
 and 873 
[M+2Na-H]
+
, positive ion HRESIMS [M+Na]
+
 m/z 851.4862 (calcd 
for C47H72O12Na 851.4921); 
Fulvyne B (13): 3.1 mg, [D +5.0 (c 0.22, CH3OH); UV (MeOH) 
max (log ) 206 (3.40); max (liquid film) 3400, 2924, 2854, 2237, 






C NMR data in Tables 7 
and 8; ESIMS m/z 851 [M+Na]
+
 and 873 [M+2Na-H]
+
, positive ion 
HRESIMS [M+Na]
+
 m/z 851.4824 (calcd for C47H72O12Na 851.4921); 
Fulvyne C (14): 11.5 mg, [D +16.8 (c 0.5, CH3OH); UV (MeOH) 
max (log ) 205 (3.40); max (liquid film) 3309, 2933, 2848, 2237, 














, positive ion HRESIMS [M+Na]
+
 m/z 851.4879 
(calcd for C47H72O12Na 851.4921); 
Fulvyne D (15): 4.2 mg, [D +3.4 (c 0.4, CH3OH); UV (MeOH) max 
(log ) 205 (3.42); max (liquid film) 3307, 2924, 2854, 2233, 1696, 














, positive ion HRESIMS [M+Na]
+
 m/z 
835.4865 (calcd for C47H72O11Na 835.4972); 
Fulvyne E (16): 8.7 mg, [D +9.4 (c 0.19, CH3OH); UV (MeOH) 
max (log ) 206 (3.36); max (liquid film) 3306, 2923, 2853, 2233, 















, positive ion 
HRESIMS [M+Na]
+
 m/z 835.4865 (calcd for C47H72O11Na 835.4972); 
Fulvyne F (17): 5.4 mg, [D +6.4 (c 0.38, CH3OH); UV (MeOH) 
max (log ) 205 (3.40); max (liquid film) 3309, 2925, 2854, 2237, 






C NMR data 







, positive ion HRESIMS [M+Na]
+
 m/z 835.4843 (calcd 
for C47H72O11Na 835.4972); 
Fulvyne G (18): 5.6 mg; [D +7.2 (c 0.31, CH3OH); UV (MeOH) 
max (log ) 205 (3.38); max (liquid film) 3310, 2920, 2851, 2237, 













, positive ion HRESIMS [M+Na]
+
 
m/z 835.4865 (calcd for C47H72O11Na 835.4972).; 
Fulvyne H (19): .4 mg, [D +12.1 (c 0.24, CH3OH); UV (MeOH) 
max (log ) 206 (3.40); max (liquid film) 3307, 2924, 2854, 2233, 






C NMR data 









, positive ion HRESIMS [M+Na]
+
 m/z 819.4990 (calcd 
for C48H76O9Na 819.5387); 
Fulvyne I (20): 2.9 mg , [D +8.6 (c 0.38, CH3OH); UV (MeOH) 
max (log ) 205 (3.42); max (liquid film) 3295, 2919, 2850, 237, 






C NMR data 





positive ion HRESIMS [M+Na]
+
 m/z 819.4917 (calcd for 
C47H72O10Na 819.5023). 
 
5.5. Experimental section for Chapter 4  
5.5.1 Placida dendritica 
 
5.5.1.1. Biological material: 86 speciments of P. dendritica were 
collected in November 2008 in the Indo-Pacific Ocean by Dr. G. 
Villani, and transferred to ICB. The molluscs were identified by Dr. 
Juan Lucas Cervera (University of Cadiz). A voucher specimen is 
stored at ICB under the code MA02. 
 
5.5.1.2. Extraction and isolation: The frozen molluscs P. dendritica 
have been treated in order to get extracts of the mantle and the internal 
glands, separately. In particular, the mantle extract was obtained 
simply by soaking the whole animals in acetone bath for few minutes, 
whereas the internal glands extract was obtained by grinding the 
animal after sonication. After filtration and evaporation in vacuo of 
the organic solvent, the two residues were subsequently extracted with 
Et2O (50 mL×4). The evaporation of Et2O gave two gummy residues 
(56 mg and 37 mg for the mantle and the gland extract respectively). 
The mantle extract was fractionated on silica gel column by eluting 
with a gradient system of light petroleum ether/Et2O, and finally 
CHCl3/MeOH 7:3. The fractions containing polypropionates were 
purified on reverse-phase HPLC column chromatography with a linear 
gradient of MeOH/H2O 80:20 until MeOH in 30 minutes (flow 1 
mL/min) to afford pure cyercene 2-4. 
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5.5.2. Peltodoris atromaculata 
 
5.5.2.1. Biological material: Three speciments of P. atromaculata 
were collected in May 2009 in Punta Pizzaco, Procida Island (Naples) 
by Dr. G. Villani at a depth of -40 m. The nudibranch was identified 
by Dr. G. Villani. A voucher specimen is stored at ICB under the code 
DA. 
 
5.5.2.2. Extraction and isolation: The frozen molluscs P. 
atromaculata were dissected into internal glands and mantle. The two 
extract were extracted separately with Me2CO. After filtration and 
evaporation in vacuo of the organic solvent, the residues were 
subsequently extracted with Et2O (20 mL×4). The evaporation of Et2O 
gave two gummy residues (15 mg and 62 mg for the mantle and the 
gland extract respectively). This latter was chromatographed on a 
Sephadex LH-20 column in CHCl3/MeOH, and then further 
fractionated on silica gel column by eluting with a gradient system of 
light petroleum ether/Et2O, CHCl3 and finally MeOH to give eight 
fractions. Preliminary 
1
H NMR analysis revealed the presence of a 
mixture of polyacetilenes that was further purified on reverse-phase 
HPLC column chromatography (MeOH; flow 1 mL/min) to afford in 
order of decreasing polarity fulvyne 1 (21, 1.4 mg), 2 (22, 1.9 mg), 3 
(23, 5.4 mg), 4 (24, 3.3 mg). 
 
5.5.2.3. Preparation of MTPA esters: Fulvyne 3 (23) was divided 
into two parts, which in turn were reacted with R-(-)-MTPA chloride 
and S-(+)-MTPA chloride, to give the S-(23a) and R-MTPA-(23b)-
esters, respectively.  
S-MTPA ester was prepared by treating 1 mg of 23 with 0.005 mL of 
R-(-)-MTPA chloride in dry CH2Cl2 (0.5 mL) with catalytic amount of 
DMAP under stirring for 16 h at room temperature. The ester was 
purified by chromatography in a Pasteur pipette (SiO2, CHCl3).  
R-MTPA ester was prepared by treating 1 mg of 23 with 0.005 mL of 
S-(+)-MTPA chloride in dry CH2Cl2 (0.5 mL) with catalytic amount 
of DMAP under stirring for 16 h at room temperature. The ester was 




Fulvyne 1 (21). Colourless oil; UV (MeOH) max (log ) 244 (3.56); 





 and HRFABMS m/z 663.5320 [M+Li-H]
+
, (calcd 
for C46H72O2Li 663,5692).  
Fulvyne 2 (22). []D -22.9 (c 0.4, CHCl3); UV (MeOH) max (log ) 





ESIMS m/z 681 [M+Na]
+
 and HRFABMS m/z 665.6318 
[M+Li-H]
+
, (calcd for C46H74O2Li 665,5849). 
Fulvyne 3 (23). []D -6.64 (c 0.3, CHCl3); IR (liquid film) max 3310, 
2925, 2854, 2098, 1455, 1232 cm
-1
; ESIMS m/z 683 [M+Na]
+
 and 
HRFABMS m/z 667.5205 [M+Li-H]
+
, (calcd for C46H76O2Li 
667,6005). 
Fulvyne 4 (24). IR (liquid film) max 3310, 2925, 2854, 2098, 1455, 
1232. from ESIMS m/z 699 [M+Na]
+
 and HRFABMS m/z 683.5065 
[M+Li-H]
+
, (calcd for C46H76O3Li 683,5955). 
5.5.3. Aldisa andersoni 
 
5.5.3.1. Biological material: Six speciments of A. andersoni were 
collected in May 2009 in the Indo-Pacific Ocean by Dr. G. Villani, 
and transferred to ICB. The nudibranches were identified by Dr. Juan 
Lucas Cervera (University of Cadiz). A voucher specimen is stored at 
ICB under the code ALDI. 
 
5.5.3.2. Extraction and isolation: The frozen molluscs A. andersoni 
have been treated in order to get extracts of the mantle and the internal 
glands, separately. In particular, the mantle extract was obtained 
simply by soaking the whole animals in acetone bath for few minutes, 
whereas the internal glands extract was obtained by grinding the 
animal after sonication. After filtration and evaporation in vacuo of 
the organic solvent, the two residues were subsequently extracted with 
Et2O (30 mL×4). The evaporation of Et2O gave two gummy residues 
(15 mg and 62 mg for the mantle and the gland extract respectively). 
The mantle extract was purified on reverse-phase HPLC column 
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chromatography with a linear gradient of MeOH/H2O 70:30 until 
MeOH in 40 minutes (flow 1 mL/min) to afford in order of decreasing 
polarity phorbazole E (25) (tR 11.8 min, 4.9 mg), F (26) (tR 19.8 min, 
1.1 mg), G (27) (tR 28.2 min, 0.8 mg). 
 
5.5.3.4. Biological assay: The antiproliferative activity were tested in 
vitro on C6 rat glioma cell line (ATCC Number: CCL-107). DMEM 
complete growth medium supplemented with fetal bovine serum to a 
final concentration of 10% (Atmosphere: air, 95%; carbon dioxide 
(CO2), 5%; Temperature: 37.0°C). The cells were continuously 
treated for 48 h with various concentrations (25, 50 , 100 and 200 µM) 
of each compound. 
 
Phorbazole E (25): 4.9 mg, UV (MeOH) max (log ) 208 (6.90), 256 
(6.80), 334 (7.01); ); IR (liquid film) max 1614, 1506, 1449, 1406, 




H NMR and 
13
C NMR in CD3OD: Table 14, 
1
H NMR and 
13
C NMR in DMSOd6: 7.73 (d, 8.42 Hz, H-12 and H-
16), 7.07 (d, 2.93 Hz, H-2), 6.94 (d, 8.42 Hz, H-13 and H-15), 6.31 (d, 
2.93 Hz, H-3); 158.3 (C-14), 151.7 (C-6), 142.1 (C-8), 126.2 (CH-12 
and CH-16), 122.5 (CH-2), 122.3 (C-9), 116.9 (C-11), 116.0 (CH-13 
and CH-15), 114.7 (C-5), 113.2 (C-4), 110.6 (CH-3). HRESIMS m/z 
316.9849 [M+Na]
+
 calcd for C13H8Cl2N2O2, found: 316,9861 
Phorbazole F (26): 1.1 mg, 
1
H NMR and 
13
C NMR in CD3OD: Table 
14.
 1
H NMR and 
13
C NMR in DMSOd6: 7.72 (d, 8.80 Hz, H-12 and 
H-16), 7.45 (s, H-2), 6.95 (d, 8.80 Hz, H-13 and H-15); 157.6 (C-14), 
151.3 (C-6), 142.3 (C-8), 126.1 (CH-12 and CH-16), 124.2 (CH-2), 
122.4 (C-9), 116.1 (C-11), 115.7 (CH-13 and CH-15), 115.3 (C-5), 
111.2 (C-4), 109.0 (C-3). HRESIMS m/z 365.2582 [M+Na]
+
 calcd for 
C14H9Cl3N2O2, found: 364.9627. 
Phorbazole G (27): 0.8 mg, 
1
H NMR and 
13
C NMR in CD3OD: Table 
14. HRESIMS m/z 384.9183 (M+Na)
+




CHAPTER 6: General Conclusion 
In the context of drug discovery, the sea has been described as 
“the last great frontier of Earth”. The oceans have an enormous 
number and diversity of life forms. During the relatively few years 
that marine organisms have been mined for useful compounds, a large 
number of bioactive chemicals have been discovered. 
Many marine invertebrates are immobile, attached to the ocean 
floor, and use highly evolved chemical compounds to attract food, 
block the growth of intruding neighbours or repel predators. It is 
believed that these survival demands triggered the evolution of a 
particularly abundant mixture of bioactive compounds. Since its 
search for anti-cancer drugs in the 1960s the US National Cancer 
Institute (NCI, Bethesda, MD, USA) has been one of the pioneers in 
the search for drugs from the sea. 
The search for bioactive compounds from marine organisms 
can be a lengthy, complex and expensive process. Once a useful 
bioactive compound is discovered, there can be a considerable 
problem in obtaining sufficient material for clinical studies, let alone 
for widespread therapeutic use. Often, to overcome this problem, one 
possibility is to develop the synthesis, even if some compounds have a 
complicated chemical structure. 
The problems associated with the effort are large, but so are 
the potential impacts on human health. The enormous biodiversity of 
107 
 
the oceans is an irreplaceable resource with many secrets yet to be 
revealed and exploited for human use. 
In the current Ph.D. research work, 7 marine organisms 
belonging to different phyla have been chemically investigated and 27 
new natural products have been isolated and characterised (Figure 23).  
In particular, the species analysed, that were collected in 
distinct geographical areas, from Antarctica to Indo-Pacific Ocean to 
Mediterranean Sea, included two species of phylum Cnidaria, 
Alcyonium antarcticum and Parazoanthus axinellae; a member of 
phylum Chordata, Pseudodistoma crucigaster; the sponge Haliclona 
fulva (phylum Porifera); and three opisthobranch species (phylum 
Mollusca), Placida dendritica, Peltodoris atromaculata, and Aldisa 
andersoni. 
The new molecules comprise two cyclic sesquiterpenes, 
alcyonicene (1) and deacetoxy-alcyonicene (2), two hydantoin 
alkaloids, parazoanthines F (3) and G (4), five linear 2-amino-alken-3-
ols, crucigasterins A-E (5-9), thirteen high molecular weight 
polyacetylenes, fulvynes A-I (12-20) and 1-4 (21-24), and, finally, 
three chlorinated phenylpyrrolyloxazoles, phorbazoles E-G (25-27). 
The structures of these compounds were determined by an extensive 
use of spectroscopic techniques, mainly NMR methods. 
Stereochemical aspects were deeply investigated for crucigasterins by 
combining spectral and chemical methods. 
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Figura 23: Summary of new natural products 
From a chemical point of view, all molecules isolated in this 
work display interesting structural elements. Alcyonicene (1) and 
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deacetoxy-alcyonicene (2) exhibited a rare bulgarane skeleton,
30
 never 
described from the marine environment and previously described only 
in essential oils from Mentha piperita
28
 and Juniperus oxycedrus.
29
 
The family of alkaloids named parazoanthines (compounds 3 and 4) 
represents an example of natural 3,5-disubstituted hydantoins that do 
not exhibit a 3-N methyl.
47 
Moreover, this rare 3,5-disubstituted 
hydantoin core constitutes a scaffold for the construction of bioactive 
molecules.
130
 Crucigasterins A-E (5-9) are 2-amino-3-alcohols with an 
unusual threo relative stereochemistry being the erythro configuration 
reported for most related molecules.
68 
Fulvynes (compounds 12-24) 
belong to the interesting group of marine polyacetylenes,
78-80
 high 
molecular weight acetogenins exhibiting several carbinol chiral 
centres (fulvynes A-I)  or less functionalised structures (fulvynes 1-4). 
Finally, phorbazoles are uncommon metabolites only reported so far 
from a Phorbas sponge.
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A series of already reported molecules were also isolated from 
the studied organisms and identified by comparison of their 
spectroscopic data with those reported in the literature. Among them, 
-pyrone propionates isolated from the sacoglossan Placida 
dendritica, cyercenes 2-4, are molecules of a certain structural 
interest. These compounds are able to interact with the light catalyzing 
the production of highly reactive singlet oxygen
131
 and undergoing 
photorearrangement reactions that lead to the isomerisation of the 





To evaluate the bioactivity of the isolated molecules, the 
attention has been focused towards antiproliferative and 
antimicrobial/antifungal activities. These studies have been carried out 
in collaboration with Prof. C. Irace (University of Naples) and Prof. R. 
Kiss (University of Bruxelles), and Prof. M. Varcamonti (University 
of Naples), respectively. 
Due to the small amounts of pure metabolites obtained, only 
selected compounds were tested against different tumour and non-
tumour cell lines in cytoxicity assays, against Gram+ and Gram– 
bacterial strains in antimicrobial tests, and against Candida albicans, 
in antifungal assays. 
All parazoanthines including the known molecules were tested 
on different human cancer cell lines - glioma (Hs683, U373, U251), 
lung (A549), breast (MCF7), melanoma (SKMEL28), prostate (PC3) - 
but none of them exhibited significant bioactivity. However, the 
evaluation of the bioactivities of these molecules is still under 
investigation, being the next step the establishment of a possible 
influence of the compounds on the cell migration, element responsible 
of the angiogenesis.  
Selected diacetyl-crucigasterins were tested for antibacterial 
and antifungal activities, exhibiting moderate activity. In particular, 
diacetyl-crucigasterins B (6a) and E (9a) were found to be active at 50 
g/mL against both Escherichia coli and Candida albicans and at 100 
g/mL against E. coli, respectively. 
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All polyoxygenated fulvynes (compounds 12-20) were tested 
in a specific assay on a chloramphenicol resistant B. subtilis strain 
(PY79), showing a strong activity against this strain (Table 11). These 
molecules were also tested on a Gram+ human pathogenic strain, 
Staphylococcus aureus, exhibiting a moderate activity. In addition, 
compound 14, the main metabolite of H. fulva, was subjected to 
cytotoxic assays. In particular, tested on different tumour cell lines – 
rat glioma (C6), rat heart (H9c2), cervical cancer (HeLa), adipose 
tissue (3T3-L1) - it showed selectivity for 3T3-L1 cell line being 
active with an IC50 of 55.7±11 μM (Table 12).  
The chemicals isolated from opisthobranchs included 
metabolites probably involved in the defensive mechanisms of the 
molluscs. These molecules were either found to be selected from the 
dietary sponges, like for P. atromaculata and A. andersoni, or 
suggested de novo biosynthesised, like for P. dendritica.  
Cyercene 4, the main metabolite of P. dendritica, was tested 
on seven human cancer cell lines (Hs683, U373, U251, A549, MCF7, 
SKMEL28, PC3). The biological activity of cyercene 4 was compared 
to that observed for aplysiopsene A,
114
 a molecule isolated from the 
sacoglossan A. formosa and structurally close to cyercene 4 (Figure 
16). Surprisingly, aplysiopsene A displayed significant in vitro growth 
inhibitory activity on various cancer cell lines (mean IC50 5±1 µM), 
while cyercene 4 was weakly active (mean IC50 = 90 µM) (Table 13). 
This different activity could be due to some structural differences 
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including the presence of the methyl group on the pyrone moiety and 
in the length of the alkyl chain (Figure 16). This aspect is currently 
under investigation. 
Phorbazoles were considered with regards with their cytotoxic 
activity. The main metabolites of A. andersoni, phorbazole E (25) and 
F (26), were assayed using a rat glioma C6 cell line. Preliminary 
results indicated a weak cytotoxicity for both molecules. 
Part of the results obtained under this Ph.D. project have been 
published on peer-reviewed international journals.
24,68,88
 Chemical 
data regarding mollusc species have to be integrated with the results 
of the biological activity evaluation - work still in progress - and will 
be submitted for publication (papers in preparation). The studies that 
have been here described represent a little but significant contribution 
to the exploring of marine environment and to the identification of 
new bioactive molecules. 
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